Sfoglia per RIVISTA
BLOOD
Collezione AOU Città della Salute di Torino

  

Items : 229

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma. in Blood / Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080.

2024
AOU Città della Salute di Torino

Musto P; Bruno B; Petrucci MT; Mancuso K; Paris L; Zambello R; Palmas AD; Gamberi B; Gozzetti A; Cellini C; Ballanti S; Velluti C; Vincelli ID; Ronconi S; Grasso M; Pavone V; Oliva S; Ledda A; Corradini P; Morè S; Belotti A; Gay F; Rota-Scalabrini D; Bertuglia G; D'Agostino M;

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. in Blood / Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625.

2024
AOU Città della Salute di Torino

Mengarelli A; Legrand O; Baron F; Candoni A; Posthuma EFM; Vrhovac R; Venditti A; Gaidano G; Crysandt M; Fuhrmann S; Foà R; Audisio E; Luppi M; Neubauer A; Griskevicius L; Chantepie S; Noppeney R; van der Velden WJFM; Coens C; Suciu S; Kicinski M; Efficace F; Fazi P; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. in Blood / Blood. 2024 Apr 4;143(14):1399-1413. doi: 10.1182/blood.2023021349.

2024
AOU Città della Salute di Torino

Mologni L; Piazza R; Gambacorti-Passerini C; Elli EM; Sessa A; Chiarle R; Azzoni E; Pagni F; Cazzaniga G; Serafini M; Mottadelli F; Stagno F; Sacco A; Cilloni D; Roccaro A; Morotti A; Corsi A; Breccia M; Riminucci M; Orsenigo R; Riera L; Barone C; Banfi F; Gengotti M; Brambilla V; Aroldi A; Sangiorgio V; Ramazzotti D; Civettini I; et alii...

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. in Blood / Blood. 2024 Apr 25;143(17):1738-1751. doi: 10.1182/blood.2023021952.

2024
AOU Città della Salute di Torino

Locatelli F; Biondi A; Valsecchi MG; Fagioli F; Parasole R; Biffi A; Möricke A; Alten J; Cario G; Feuerstein T; Bourquin JP; Karawajew L; Zaliova M; Schinnerl D; Strehl S; Zimmermann M; Scarparo P; Szczepanowski M; Hrusak O; Cazzaniga G; Mejstrikova E; Brüggemann M; Gaipa G; Schumich A; Maurer-Granofszky M; Varotto E; Buldini B; Attarbaschi A; Schrappe M; et alii...

Looking for a needle in the haystack of CLL. in Blood / Blood. 2023 Feb 2;141(5):445-447. doi: 10.1182/blood.2022018077.

2023
AOU Città della Salute di Torino

Genuardi E; Ferrero S;

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma. in Blood / Blood. 2022 Sep 22;140(12):1378-1389. doi: 10.1182/blood.2021014270.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Alessandria

Liberati AM; Ladetto M; Cortelazzo S; Ghiggi C; Cascavilla N; Musuraca G; Hohaus S; Re F; Petrini M; Pavone V; Casaroli I; Castellino C; Zanni M; Benedetti F; Stefani PM; De Luca G; Evangelista A; Genuardi E; Drandi D; Zaccaria GM; Alessandria B; Ghislieri M; Mantoan B; Ferrante M; Ferrero S; Grimaldi D;

MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials. in Blood / Blood. 2022 Sep 21:blood.2022016782. doi: 10.1182/blood.2022016782.

2022
AOU Città della Salute di Torino

Wang B; Estevam J; Vorog A; Li C; Rojas C; Fu W; Suryanarayan K; Cavo M; Giuliani N; Mateos MV; Teipel R; Spicka I; Zweegman S; Min CK; Gay F; Dimopoulos MA; Manrique I; Paiva B; Labotka R; Dash AB;

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. in Blood / Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.

2022
ASL Torino 4
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Visco C; Dreyling M; Seymour JF; Stefani PM; Sciarra R; Chiappella A; Vitagliano O; Sartori R; Mannina D; Morello L; Nicoli P; Arcari A; Angelillo P; Williams ME; Marin-Niebla A; Cencini E; van Meerten T; Mocikova H; Duglosz-Danecka M; Auer RL; Pagani C; Bernard S; Infante G; Iadecola S; Crucitti L; Muzi C; Klener P; Giné E; Tucker D; et alii...

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. in Blood / Blood. 2022 Mar 10;139(10):1588-1592. doi: 10.1182/blood.2021014124.

2022
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Jiménez-Lorenzo MJ; Hernández-Rivas JÁ; Jaksic O; Busca A; Corradini P; Pagliuca A; Koehler P; Klimko N; Hoenigl M; Rá?il Z; Karlsson LK; Nunes-Rodrigues R; González-López TJ; Malak S; Loureiro-Amigo J; Glenthøj A; Córdoba-Mascuñano R; Weinbergerová B; Serrano L; Ribera-Santa Susana JM; Calbacho M; Bilgin YM; Sili U; van Doesum J; Labrador J; Falces-Romero I; Dragonetti G; Pagano L; Gomes-Silva M; et alii...

High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. in Blood / Blood. 2022 Mar 10;139(10):1557-1563. doi: 10.1182/blood.2021012890.

2022
AOU Città della Salute di Torino

Langerak AW; Hultdin M; McKay JD; Vermeulen RCH; Engelfriet P; Nieters A; Schulze MB; Sacerdote C; Grioni S; Chirlaque MD; Masala G; Sánchez MJ; Besson C; Jerkeman M; Agudo A; Barricarte A; Benavente Y; Casabonne D; Hengeveld PJ; Agathangelidis A; Saleh M; Kolijn PM; Hosnijeh FS; Späth F;

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.

2022
ASL Città di Torino
AOU Città della Salute di Torino
AOU Alessandria
AOU San Luigi di Orbassano

Cornely OA; Busca A; Koehler P; Hoenigl M; Corradini P; Pagliuca A; Passamonti F; Bonanni M; Sili U; Machado M; Rahimli L; Adži?-Vuki?evi? T; Labrador J; Verga L; Cattaneo C; Gräfe S; Hanáková M; Mladenovi? M; Liévin R; Nucci M; Prezioso L; Marchetti M; Rá?il Z; Demirkan F; Sacchi MV; Guidetti A; Fouquet G; Fernández N; Zambrotta G; et alii...

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL. in Blood / Blood. 2022 Dec 1;140(22):2348-2357. doi: 10.1182/blood.2022016901.

2022
ASL Vercelli
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Ghia P; Ranghetti P; Sancetta R; Perotta E; Varettoni M; Rivela P; Laurenti L; Capasso A; Coscia M; Ferrario A; Reda G; Motta M; Deodato M; Farina L; Moia R; Schiattone L; Heltai S; Albi E; Scarano E; Scarfò L; Colia M;

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. in Blood / Blood. 2022 Apr 21;139(16):2499-2511. doi: 10.1182/blood.2021014506.

2022
AOU Città della Salute di Torino

McKay P; Cwynarski K; Cheah CY; Miall F; Fox CP; Tchernonog E; Smith J; Barlow BR; Guidetti A; Scott H; Clavert A; Htut TW; Strüßmann T; Agbetiafa K; Lees C; Forgeard N; Gounder P; O'Mahony D; Lopez-Garcia A; Hamad N; Manos K; Fernandez R; Lombion N; Roulin L; Vassallo F; Lebras L; Zayac AS; Liu Q; Shah N; et alii...

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43) in Blood

2022
AOU Città della Salute di Torino

Illerhaus G; Ferreri AJM; Binder M; Borchmann P; Hasenkamp J; Stilgenbauer S; Roeth A; Weber T; Egerer G; Ernst T; Hertenstein B; Lenz G; Kobbe G; Brunnberg U; Schmidt C; Kneba M; Dreyling M; Möhle R; Panse J; Heinicke T; Schroll S; Larsen TS; Salwender H; Naumann R; Hess G; Thurner L; Pukrop T; Keller U; Blystadt AK; et alii...

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma. in Blood / Blood. 2021 Mar 4;137(9):1154-1165. doi: 10.1182/blood.2020008209.

2021
AOU Città della Salute di Torino

Vij R; Paiva B; Macé S; Hellet M; Saleem R; Yin JY; Ruiz EY; Vorobyev V; Jenner M; Hungria V; Gasparetto C; Cole C; Capra M; Cavo M; Anttila P; Bringhen S; Dimopoulos M;

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. in Blood / Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.

2021
AOU Città della Salute di Torino
AOU Novara

Jelinek D; Haferlach C; Stilgenbauer S; Hallek M; Oscier D; Fischer K; Anagnostopoulos A; Pott C; Campo E; Niemann C; Francia di Celle P; Gaidano G; Stavroyianni N; Trentin L; Montillo M; Antic D; Foroni L; Espinet B; Costeas P; Panagiotidis P; Alshemmari S; Rossi D; Panovska I; Kater AP; Fais F; Bödör C; Sandaltzopoulos R; Karan-Djurasevic T; Mansouri L; et alii...

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma. in Blood / Blood. 2021 Jun 3;137(22):3027-3036. doi: 10.1182/blood.2020009507.

2021
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Tacchetti P; Boccadoro M; Bringhen S; Corradini P; Patriarca F; Caravita di Toritto T; Pompa A; Monaco F; Cellini C; Giuliani N; Bernardini A; Rota-Scalabrini D; Antonioli E; Marasca R; Galli M; Tosi P; Benevolo G; Cascavilla N; Capra A; Offidani M; Gaidano G; D'Agostino M; Bonello F; Larocca A;

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Griggio V; Vitale C; Coscia M; Salvetti C; Gaidano G; Mauro FR; Foà R; Boccadoro M; Scarfò L; Cuneo A; Tedeschi A; Reda G; Orsucci L; Trentin L; De Paoli L; Montalbano MC; Boccellato E; Perutelli F; Marchetti M; Pennese E; Gentile M; Rivela P; Murru R; Laurenti L; Rigolin GM; Vassallo F; Cassin R; Porrazzo M; Schiattone L; et alii...

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. in Blood / Blood. 2021 Jul 22;138(3):213-220. doi: 10.1182/blood.2020010387.

2021
AOU Città della Salute di Torino

Radford J; Vitolo U; Montoto S; Inghirami G; Pileri SA; Dlouhy I; Vassallo J; Cabrera ME; Hitz F; Horwitz SM; Shustov AR; Kim WS; Spinner MA; Manni M; Civallero M; Advani RH; Skrypets T; Vose JM; Federico M;

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants. in Blood / Blood. 2021 Apr 8;137(14):1980-1984. doi: 10.1182/blood.2020009032.

2021
AOU Città della Salute di Torino

Cazzaniga G; Locatelli F; Valsecchi MG; Biondi A; Rizzari C; Conter V; Favre C; Vinti L; Zecca M; Barisone E; Parasole R; Buldini B; Palmi C; Palamini S; Corral Abascal L; Pedace L; Quadri M; Grioni A; De Lorenzo P; Bardini M; Fazio G;

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide. in Blood / Blood. 2021 Apr 22;137(16):2267-2271. doi: 10.1182/blood.2020008609.

2021
AOU Città della Salute di Torino

Herling CD; Brüggemann M; Eichhorst B; Hallek M; Fischer K; Tausch E; Ritgen M; Stilgenbauer S; Weppner G; Böttcher S; Coscia M; Vitale C; Crespo M; de la Serna J; Eckert R; Robrecht S; Weiss J; Schilhabel A; Fink AM; Fürstenau M;

A Randomized, Phase 3 Trial of Fedratinib Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Previously Treated with Ruxolitinib (FREEDOM2) in Blood

2021
AOU Città della Salute di Torino

Vianelli N; Benevolo G; Vannucchi A; Harrison CN; Loschi M; Al-Ali HK; Bonifacio M; Cervantes F; Wrobel T; Barosi G; Kiladjian J-J; Verstovsek S; Mesa RA; Rose S; Gharpure V; Hernandez C; Zhang J; Passamonti F;

Real-World Patterns of Utilization and Outcome of Market Approved Lenalidomide-Based Triplet Combinations in First Relapsed Multiple Myeloma Patients: Evidence from a Propensity Score Matched Analysis in Blood

2021
AOU Città della Salute di Torino

Mangiacavalli S; Galli M; Pezzatti S; Belotti A; Fazio F; Marcatti M; Cafro AM; Mina R; Zambello R; Paris L; Cartia CS; Barilà G; Olivares C; Pompa A; Mazza R; Farina F; Soldarini M; Benvenuti P; Lecci M; Ferretti VV; Petrucci MT;

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma in Blood

2021
AOU Città della Salute di Torino

Efficace F; Gaidano G; Petrucci MT; Niscola P; Tognazzi L; Antonioli E; Cottone F; Annibali O; Tafuri A; Califano C; Larocca A; Potenza L; Palazzo G; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Tosi P; Kyriakou C; Cascavilla N; Molica S; Gozzetti A; Derudas D; Vignetti M; Cavo M;

Posaconazole at Standard Dose Is Safe and More Effective Than Echinocandins As IFD Prophylaxis in Patients with FLT3 Mutated AML Treated with Midostaurin in Blood

2021
AOU Città della Salute di Torino

Cattaneo C; Marchesi F; Bonuomo V; Fracchiolla NS; Candoni A; Criscuolo M; Prezioso L; Pasciolla C; Del Principe MI; Dargenio M; Tarantini G; Mitra ME; Farina F; Colnaghi F; Sciumè M; Nadali G; Busca A; Rossi G; Pagano L;

Rituximab Plus Bendamustine and Cytarabine (R-BAC) in Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma: Long Term Follow-up and Mrd Results of a Phase 2 Study from the Fondazione Italiana Linfomi in Blood

2021
AOU Città della Salute di Torino

Tisi MC; Nassi L; Patti C; Spina M; Ferrero S; Tani M; Botto B; Molinari AL; Puccini B; Cencini E; Di Rocco A; Chini C; Ghiggi C; Zambello R; Zanni M; Sciarra R; Ferrante M; Stelitano C; Re A; Volpetti S; Zilioli VR; Arcari A; Merli F; Visco C;

Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi in Blood

2021
AOU Città della Salute di Torino

Merli F; Spina M; Tucci A; Rigacci L; Cavallo F; Cabras MG; Alvarez I; Fabbri A; Re A; Puccini B; Ferrero S; Usai SV; Ferrari A; Cencini E; Pennese E; Zilioli VR; Marino D; Balzarotti M; Cox MC; Zanni M; Di Rocco A; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Nassi L; Musuraca G; et alii...

The Tigit/CD226/CD155 Immunomodulatory Axis Is Deregulated in CLL and Contributes to B-Cell Anergy in Blood

2021
AOU Città della Salute di Torino

Arruga F; Iannello A; Ioannou N; Todesco AM; Coscia M; Moia R; Gaidano G; Allan JN; Furman R; Vaisitti T; Ramsay AG; Deaglio S;

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey in Blood

2021
AOU Città della Salute di Torino

Giannotta JA; Fattizzo B; Girmenia C; Ielo C; Metafuni E; Visentin A; Bianchi P; Apolito V; Beggiato E; Di Bona E; Sica S; Iori AP; Barcellini W;

Blinatumomab and Inotuzumab for the Treatment of Multiply Relapsed Acute Lymphoblastic Leukemia: A Real-Life Campus ALL Study in Blood

2021
AOU Città della Salute di Torino

Sciumè M; Papayannidis C; Curti A; Vitale A; Chiaretti S; Annunziata M; Giglio F; Salutari P; Forghieri F; Lazzarotto D; Lunghi M; Imovilli A; Scappini B; Bonifacio M; Dargenio M; Gurrieri C; Todisco E; Defina M; Del Principe MI; Zappasodi P; Cerrano M; Santoro L; Barozzi E; De Roberto P; Buzzatti E; Sartor C; Baldini L; Foa R; Fracchiolla NS; et alii...

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program in Blood

2021
AOU Città della Salute di Torino

Minetto P; Guolo F; Fianchi L; Clavio M; Gottardi M; Endri M; Galimberti S; Rizzuto G; Sciumé M; Rondoni M; Bertani G; Dargenio M; Billio A; Scappini B; Zappasodi P; Scattolin AM; Grimaldi F; Pietrantuono G; Musto P; Marco C; D'Ardia S; Audisio E; Cignetti A; Pasciolla C; Pavesi F; Candoni A; Gurrieri C; Morselli M; Alati C; et alii...

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Luminari S; Nizzoli ME; Chiarenza A; Mannina D; Tucci A; Boccomini C; Farina L; Olivieri J; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Re F; Balzarotti M; Ladetto M; Patti C; Pinto A; Cabras MG; Musto P; Gini G; Arcari A; Manni M; Versari A; Federico M; et alii...

Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1) in Blood

2021
AOU Città della Salute di Torino

Kharfan-Dabaja MA; Labopin M; Ayala E; Bazarbachi A; Blaise D; Koc Y; Vydra J; Busca A; Castagna L; Novis Y; McDonald A; Bulabois C-E; Schmid C; Herrera Arroyo C; Forcade E; Ciceri F; Sanz J; Nagler A; Mohty M;

Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL in Blood

2021
AOU Città della Salute di Torino

Chatzikonstantinou T; Scarfo L; Demosthenous C; Kotaskova J; Iacoboni G; Minga E; Chammou D; Karakatsoulis G; Albi E; Alcoceba M; El-Ashwah S; Bacchiarri F; Khan MA; Aurran T; Calleja A; Cassin R; Chatzileontiadou S; Christian A; Claus R; Collado R; De Deus Santos MD; Davis Z; Dimou M; Donaldson D; Dos Santos G; Dreta B; Efstathopoulou M; Enrico A; Fresa A; et alii...

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey) in Blood

2021
AOU Città della Salute di Torino

Marchesi F; Salmanton-García J; Lopez-Garcia A; Dragonetti G; Sili U; Glenthoej A; Buquicchio C; Mikulska M; Weinbergerova B; Busca A; Corradini P; Hoenigl M; Klimko NN; Pagliuca A; Passamonti F; Köhler P; Cornely O; Pagano L;

BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress) in Blood

2021
AOU Città della Salute di Torino

Jurczak W; Dartigeas C; Coscia M; Ganly PS; Al-Jazayrly G; Wang C; Bao K; Leow CC; Shahda S; Zinzani PL;

Efficacy of Front-Line Ibrutinib Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) in Patients with CLL. a Multicenter “Real-World” Study in Blood

2021
AOU Città della Salute di Torino

Herishanu Y; Levi S; Goldschmidt N; Morabito F; Bairey O; Del Poeta G; Ziv Baran T; Fineman R; Mauro FR; Gutwein O; Reda G; Ruchlemer R; Sportoletti P; Laurenti L; Shvidel L; Coscia M; Tadmor T; Varettoni M; Aviv A; Murru R; Breaster A; Bronstein Y; Chiarenza A; Visentin A; Pietrasanta D; Loseto G; Zucchetto A; Bomben R; Olivieri J; et alii...

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem in Blood

2021
AOU Città della Salute di Torino

Chiappella A; Guidetti A; Dodero A; Bramanti S; Zinzani PL; Santoro A; Casadei B; Di Rocco A; Carrabba MG; Chiusolo P; Martino M; Barbui AM; Tisi MC; Saccardi R; Perriello VM; Orciuolo E; Botto B; Russo D; Miceli R; Ljevar S; Carniti C; Corradini P;

Treatment of Patients with Relapsed or Refractory Primary CNS Lymphoma (rrPCNSL) Enrolled in the Randomized Trials of the International Extranodal Lymphoma Study Group (IELSG) in Blood

2021
AOU Città della Salute di Torino

Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; La Rosée P; Schorb E; Krampera M; Ilariucci F; Orsucci L; Fabbri A; Tucci A; Roeth A; Linton K; Binder M; Hemmaway C; Cabras MG; Pinto A; Calimeri T; Cavalli F; Zucca E; Illerhaus G;

ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report in Blood

2021
AOU Città della Salute di Torino

Chiaretti S; Bonifacio M; Agrippino R; Annunziata M; Candoni A; Marco C; Cedrone M; Ciccone M; Chiusolo P; Curti A; Dargenio M; Defina M; Delia M; Del Principe MI; Endri M; Fava C; Forghieri F; Fiorentini A; Giglio F; Grimaldi F; Guolo F; Lamanda M; Lunghi M; Lussana F; Mancini V; Mazzone C; Mulè A; Pasciolla C; Piccini M; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial in Blood

2021
AOU Città della Salute di Torino

Ladetto M; Ferrero S; Del Giudice I; Galimberti S; Gattei V; Marcheselli L; Mantoan B; Genuardi E; Alessandria B; Ferrante M; Dogliotti I; Della Starza I; De Novi LA; Cavalli M; Grassi S; Ciabatti E; Guerrini F; Bomben R; Degan M; Zaina E; Perrone T; Petrini M; Re F; Olivieri A; Usai SV; Mannina D; Falini B; Rota Scalabrini D; Stefani PM; et alii...

An Observational Study on Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens Outside Clinical Trials in Italy (GIMEMA CLL1920) in Blood

2021
AOU Città della Salute di Torino

Scarfo L; Albi E; Quaglia FM; Marasca R; Sanna A; Murru R; Laurenti L; Gaidano G; Mannina D; Gentile M; Patti C; Reda G; Piciocchi A; Fazi P; Soddu S; Pietrasanta D; Orsucci L; Molica S; Ferrario A; Ferrari A; Sportoletti P; Angeletti I; Galimberti S; Chiarenza A; Morelli F; Mauro F; Cuneo A; Ghia P;

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study in Blood

2021
AOU Città della Salute di Torino

Malagola M; Polverelli N; Martino M; Rubini V; Lupo Stanghellini MT; Patriarca F; Fanin R; Bruno B; Giaccone L; Faraci DG; Grillo G; Bramanti S; Castagna L; Bernasconi P; Colombo AA; De Gobbi M; Nicoli P; Natale A; Santarone S; Terruzzi E; Olivieri A; Scortechini I; Chiusolo P; Metafuni E; Carella AM; Merla E; Casini M; Cavattoni IM; Arpinati M; et alii...

First Interim Analysis of the Italian Dante Study: De-Escalation before Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with First-Line Nilotinib in Blood

2021
AOU Città della Salute di Torino

Breccia M; Abruzzese E; Stagno F; Iurlo A; Pene F; Attolica I; Sportoletti P; Pregno P; Galimberti S; Scappini B; Lemoli RM; Siragusa S; Capodanno I; Chiodi F; Saglio GN; Rosti G;

Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) in Blood

2021
AOU Città della Salute di Torino

Gavriilaki E; Sakellari I; Labopin M; Salmenniemi U; Yakoub-Agha I; Potter V; Berceanu A; Rambaldi A; Hilgendorf I; Kröger N; Mielke S; Zuckerman T; Sanz J; Busca A; Ozdogu H; Savani BB; Giebel S; Bazarbachi A; Spyridonidis A; Nagler A; Mohty M;

Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic in Blood

2021
AOU Città della Salute di Torino

Beksac M; Tuglular T; Unal A; Cavo M; Gay F; Katodritou E; Ozsan GH; Cengiz G; Sevindik OG; Merante S; Manousou K; Sonneveld P; Terpos E;

Peripheral Blasts Are Associated with Response to Ruxolitinib and Outcome in Patients with Chronic-Phase Myelofibrosis in Blood

2021
AOU Città della Salute di Torino

Palandri F; Bartoletti D; Abruzzese E; Iurlo A; Bonifacio M; Caocci G; Elli EM; Auteri G; Tiribelli M; Polverelli N; Martino B; Miglino M; Heidel FH; Tieghi A; Benevolo G; Beggiato E; Fava C; Cavazzini F; Pugliese N; Binotto G; Bosi C; Crugnola M; Ottaviani E; Di Pietro C; Micucci G; Trawinska MM; Cuneo A; Bocchia M; Krampera M; et alii...

Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea in Blood

2021
AOU Città della Salute di Torino

Latagliata R; Bartoletti D; Andriani A; Breccia M; Rossi E; Auteri G; Heidel FH; Elli EM; Pugliese N; Mendicino F; Benevolo G; Martino B; D'Addio A; Tieghi A; Di Veroli A; Binotto G; Crugnola M; Bonifacio M; Caocci G; Cavazzini F; Tiribelli M; Vianelli N; Cavo M; Palumbo GA; De Stefano V; Palandri F;

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. in Blood / Blood. 2020 May 21;135(21):1833-1846. doi: 10.1182/blood.2019003807.

2020
ASL Città di Torino
AOU Città della Salute di Torino

Santos A; Rosenblum F; Sanders PW; Rocatello D; Rennke HG; Rabant M; Pani A; Motwani SS; Manso R; Maletta F; Lepori N; Knebelmann B; Herrera GA; Goujon JM; Gougeon F; Fenoglio R; Fatima H; Drosou ME; Cohen C; Bianco P; Barreca A; Asunis AM; Alexander MP; Angioi A; Adam BA; LeBlanc R; Nasr SH; Écotière L; Troyanov S; et alii...

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. in Blood / Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.

2020
AOU Città della Salute di Torino

Luciani M; Brueckmann M; Gropper S; Kreuzer J; Huang F; Sun Z; Simetzberger M; Tartakovsky I; Zapletal O; Kuhn T; Svirin P; Nurmeev I; Mitchell LG; Chalmers E; Halton J; Bomgaars L; Albisetti M; Brandão LR;

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. in Blood / Blood. 2020 Dec 24;136(26):3033-3040. doi: 10.1182/blood.2020008150.

2020
AOU Città della Salute di Torino

Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H;

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Foà R; Marasca R; Laurenti L; Trentin L; Mauro FR; Gattei V; Ibatici A; Rigolin GM; Orsucci L; Pietrasanta D; Re F; Marchetti M; De Paoli L; Varettoni M; Quaglia FM; Reda G; Scarfò L; Cuneo A;

First Line Treatment with Hydroxyurea in Patients with Policitemia Vera: Evaluation of Efficacy in the Current Clinical Practice Beyond ELN Criteria in Blood

2020
AOU Città della Salute di Torino

Latagliata R; Breccia M; Di Veroli A; Benevolo G; Elli EM; Cavazzini F; Binotto G; Tieghi A; Tiribelli M; Heidel FH; Bonifacio M; Pugliese N; Caocci G; Crugnola M; Mendicino F; Martino EA; D'Addio A; Tomassetti S; Martino B; Bartoletti D; Auteri G; Catani L; Stella R; D'Amore F; Scaffidi L; Polverelli N; Pane F; Cuneo A; Krampera M; et alii...

Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study in Blood

2020
AOU Città della Salute di Torino
AOU Alessandria

Scarfo L; Heltai S; Albi E; Scarano E; Schiattone L; Farina L; Gaidano G; Deodato M; Ferrario A; Motta M; Reda G; Sancetta R; Coscia M; Ladetto M; Laurenti L; Varettoni M; Perotta E; Capasso A; Ranghetti P; Colia M; Ghia P;

A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice in Blood

2020
AOU Città della Salute di Torino

Nanni J; Audisio E; Giannini MB; Scappini BM; Cambò B; Albano F; Martelli MP; Cignetti A; Rigolin GM; Fracchiolla N; Bocchia M; Romani C; Todisco E; Lunghi M; Mianulli AM; Cilloni D; Petracci E; Valli I; Zingaretti C; Cerchione C; Cangini D; collaborative Group TF; Papayannidis C; Martinelli G;

Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus in Blood

2020
ASL Asti
AOU Città della Salute di Torino

Visentin A; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfo L; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;

Progression-Free Survival (PFS) Benefit Demonstrated and Quality of Life (QoL) Maintained across Age and Frailty Subgroups with the Oral Proteasome Inhibitor (PI) Ixazomib Vs Placebo As Post-Induction Maintenance Therapy in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Analysis of the TOURMALINE-MM4 Phase 3 Trial in Blood

2020
AOU Città della Salute di Torino

Bringhen S; Pour L; Benjamin R; Grosicki S; Min C-K; De Farias DLC; Vorog A; Labotka RJ; Wang B; Cherepanov D; Cain LE; Manne S; Rajkumar SV; Dimopoulos MA;

The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World in Blood

2020
AOU Città della Salute di Torino

Thieblemont C; Chartier L; Dührsen U; Vitolo U; Barrington SF; Vercellino L; Zaucha J; Patrocinio Carvalho I; Maria GDS; Decazes P; Viailly P-J; Tilly H; Berriolo-Riedinger A; Casasnovas R-O; Hüttmann A; Ilyas H; Mikhaeel G; Dunn J; Cottereau AS; Schmitz C; Paulson JN; Nielsen TG; Meignan M;

Efficacy of Idelalisib and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Treated Outside of Clinical Trial. a Report of the Gimema Group in Blood

2020
AOU Città della Salute di Torino

Rigolin GM; Frustaci A; Piciocchi A; Visentin A; Vitagliano O; Coscia M; Farina L; Gaidano G; Murru R; Varettoni M; Arcaini L; Cibien F; Paolini R; Sportoletti P; Pietrasanta D; Molinari AL; Quaglia FM; Laurenti L; Marasca R; Marchetti M; Chiarenza A; Mauro FR; Perbellini O; Mannina D; Sancetta R; Olivieri A; Molica S; Pane F; Patti C; et alii...

Differential Treatment Strategy in Polycythemia Vera Patients with Stable Suboptimal Response to Hydroxyurea: Clinical Correlations and Impact on Survival in Blood

2020
AOU Città della Salute di Torino

Palandri F; Bartoletti D; Benevolo G; Breccia M; Elli EM; Cavazzini F; Binotto G; Tieghi A; Tiribelli M; Heidel FH; Bonifacio M; Pugliese N; Caocci G; Crugnola M; Mendicino F; Martino EA; D'Addio A; Tomassetti S; Martino B; Auteri G; Catani L; Stella R; D'Amore F; Scaffidi L; Polverelli N; Pane F; Cuneo A; Krampera M; Semenzato G; et alii...

Revealing Transcriptome Deregulation upon Genomic Complexity in Multiple Myeloma in Blood

2020
AOU Città della Salute di Torino

Da Via' MC; Ziccheddu B; Dugo M; Lionetti M; Todoerti K; D'Agostino M; Neri A; Baldini L; Corradini P; Maura F; Bolli N;

COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy in Blood

2020
AOU Città della Salute di Torino

Barcellini W; Fattizzo B; Quattrocchi L; Giannotta JA; Aydin S; Barone F; Carbone C; Beggiato E; Bianchi P; Di Bona E; Notaro R; Iori AP;

Italian Observational Study on Real-Life Use of Venetoclax in Acute Myeloid Leukemia (AVALON study): Results of Interim Analysis on Relapsed/Refractory Patients in Blood

2020
AOU Città della Salute di Torino

Todisco E; Fracchiolla N; Papayannidis C; Martelli MP; Rizzuto G; Cignetti A; Di Renzo N; Zappasodi P; Gottardi M; Audisio E; Lunghi M; Gigli F; Tarella C; Zingaretti C; Petracci E; Volpi R; Cangini D; Giannini MB; Sciumè M; Rossi G; Group A; Martinelli G; Cerchione C;

HORIZON (OP-106): Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma-Age Subgroup Analysis of Elderly Patients in Blood

2020
AOU Città della Salute di Torino

Larocca A; Richardson PG; Oriol A; Blade Creixenti J; Cavo M; Rodríguez-Otero P; Leleu X; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Thuresson M; Harmenberg J; Gustavsson B; Mateos M-V;

Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib in Blood

2020
AOU Città della Salute di Torino

Caocci G; Mulas O; Capodanno I; Annunziata M; Abruzzese E; Galimberti S; Tiribelli M; Luciano L; Martino B; Castagnetti F; Binotto G; Pregno P; Stagno F; Bocchia M; Albano F; Luzi D; Fozza C; Bonifacio M; Elena C; Gozzini A; Simula MP; Trawinska MM; Baratè C; Stella R; De Gregorio F; Gugliotta G; Pirillo F; Cattaneo D; Sicuranza A; et alii...

Worldwide Examination of Patients with CLL Hospitalized for COVID-19 in Blood

2020
ASL Asti
AOU Città della Salute di Torino

Roeker LE; Scarfo L; Chatzikonstantinou T; Abrisqueta P; Eyre TA; Cordoba R; Muntañola Prat A; Villacampa G; Leslie LA; Koropsak M; Quaresmini G; Allan JN; Furman RR; Bhavsar EB; Pagel JM; Hernandez-Rivas JA; Patel K; Motta M; Bailey N; Miras F; Lamanna N; Alonso R; Osorio-Prendes S; Vitale C; Kamdar M; Baltasar P; Österborg A; Hanson L; Baile M; et alii...

HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)-Analysis of Adverse Events Related to Hospitalizations in Blood

2020
AOU Città della Salute di Torino

Nadeem O; Richardson PG; Mateos M-V; Oriol A; Larocca A; Blade Creixenti J; Rodríguez-Otero P; Leleu X; Norkin M; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Sandberg A; Pelaez I; Jaques C; Orre M; Cavo M;

Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus in Blood

2020
AOU Città della Salute di Torino

Di Maio N; Russo G; Barella S; Forni GL; Colombatti R; Notarangelo L; Graziadei G; Sau A; Rigoli L; Farruggia P; Campisi S; Casini T; Balocco M; Boscarol G; Capolsini I; Grotto P; Giona F; Lazzareschi I; Pugliese P; Fioredda F; Fasoli S; Putti MC; Migliavacca M; Paola C; Tripodi S; Saracco P; Ferrero S; Tornesello A; Serra M; et alii...

Ruxolitinib Rechallenge in Resistant/Intolerant MF Patients: Frequency, Therapeutic Effects, and Impact on Outcome in Blood

2020
AOU Città della Salute di Torino

Palandri F; Tiribelli M; Breccia M; Bartoletti D; Elli EM; Benevolo G; Martino B; Cavazzini F; Tieghi A; Iurlo A; Pugliese N; Crugnola M; Binotto G; Caocci G; Auteri G; Cattaneo D; Catani L; Stella R; Scaffidi L; Polverelli N; Micucci G; Masselli E; Bosi C; Heidel FH; Latagliata R; Pane F; Cuneo A; Krampera M; Semenzato G; et alii...

HORIZON (OP-106) Versus MAMMOTH: An Indirect Comparison of Efficacy Outcomes for Patients with Relapsed/Refractory Multiple Myeloma Refractory (RRMM) to Anti-CD38 Monoclonal Antibody Therapy Treated with Melflufen Plus Dexamethasone Versus Conventional Agents in Blood

2020
AOU Città della Salute di Torino

Blade Creixenti J; Mateos M-V; Oriol A; Larocca A; Cavo M; Rodríguez-Otero P; Leleu X; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Zavisic S; Thuresson M; Harmenberg J; Richardson PG;

Direct Oral Anticoagulants for Myeloproliferative Neoplasms (MPN-DOACs): Results from an International Study on 442 Patients in Blood

2020
AOU Città della Salute di Torino

Barbui T; De Stefano V; Carobbio A; Iurlo A; Alvarez-Larran A; Vannucchi AM; Palandri F; Harrison C; Sibai H; Griesshammer M; Bonifacio M; Elli EM; Trotti C; Koschmieder S; Carli G; Benevolo G; Ianotto J-C; Goel S; Falanga A; Betti S; Cattaneo D; Arellano-Rodrigo E; Mannelli L; Vianelli N; Doyle A; Gupta V; Wille K; Tremblay D; Mascarenhas J; et alii...

HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed to Prior Alkylator Therapy-Subgroup Analysis in Blood

2020
AOU Città della Salute di Torino

Rodríguez-Otero P; Mateos M-V; Oriol A; Larocca A; Blade Creixenti J; Cavo M; Leleu X; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Thuresson M; Harmenberg J; Harlin O; Richardson PG;

First Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Blood

2020
AOU Città della Salute di Torino

van de Donk NWCJ; Popat R; Larsen J; Minnema MC; Jagannath S; Oriol A; Zonder J; Richardson PG; Rodriguez-Otero P; Badros AZ; Stadtmauer E; Bringhen S; Campagnaro E; Siegel DS; Gamberi B; Gironella Mesa M; Sonneveld P; Nguyen TV; Di Micco A; Sorrell A; Chen M; Amatangelo M; Kueenburg E; Lonial S;

HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in 55 Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)-Subgroup Analysis in Blood

2020
AOU Città della Salute di Torino

Richardson PG; Mateos M-V; Oriol A; Larocca A; Cavo M; Rodríguez-Otero P; Leleu X; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Zamagni E; Thuresson M; Harmenberg J; Harlin O; Blade Creixenti J;

HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Health-Related Quality of Life (HRQoL) Analysis in Blood

2020
AOU Città della Salute di Torino

Oriol A; Richardson PG; Mateos M-V; Larocca A; Blade Creixenti J; Cavo M; Rodríguez-Otero P; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Strang P; Sandberg A; Jaques C; Thuresson M; Orre M; Leleu X;

RNA Sequencing Analysis in Primary Mediastinal B Cell Lymphoma: Identification of Different Gene Expression Related to Chemoresistance in Blood

2020
AOU Città della Salute di Torino

Parvis GE; Incarnato D; Torti D; Familiari U; Vassallo F; Carrà G; Oliviero S; Volante M; Guerrasio A; Saglio G; Morotti A;

Multicenter Long Term Follow-up in Hairy Cell Leukemia Patients Treated with Cladribine: A Thirty-Year Experience in Blood

2020
AOU Città della Salute di Torino

Criscuolo M; Broccoli A; Galli E; Piciocchi A; Maraglino A; Anastasia A; Annibali O; Cantonetti M; De Luca ML; Fianchi L; Frustaci A; Galli E; Guarnera L; Kovalchuk S; Marchesi F; Motta M; Nizzoli ME; Offidani M; Orsucci L; Spolzino A; Stelitano C; Storti S; Tedeschi A; Trentin L; Varettoni M; Visentin A; Volpetti S; Falini B; Pulsoni A; et alii...

Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL) in Blood

2020
AOU Città della Salute di Torino

Ferrero S; Grimaldi D; Arrigoni E; Zaccaria GM; Alessandria B; Genuardi E; De Luca G; Ghislieri M; Di Rocco A; Re A; Stefoni V; Cavallo F; Boccomini C; Balzarotti M; Zilioli VR; Maria GDS; Arcaini L; Molinari AL; Ballerini F; Ferreri AJ; Puccini B; Palumbo GA; Galimberti S; Cortelazzo S; Di Paolo A; Ladetto M;

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT in Blood

2020
AOU Città della Salute di Torino

Fein JA; Shouval R; Labopin M; Ciceri F; Angelucci E; Blaise D; Tischer J; Arcese W; Koc Y; Bruno B; Diez-Martin JL; Santarone S; Sica S; Versluis J; Mohty M; Nagler A;

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT in Blood

2020
AOU Città della Salute di Torino

Battipaglia G; Galimard J-E; Labopin M; Angelucci E; Blaise D; Ruggeri A; Gulbas Z; Díez-Martín JL; Koc Y; Castagna L; Vitek A; Sica S; Bruno B; Moiseev IS; Rovira M; Martino M; Araujo MC; Arat M; Grillo G; Martin H; Corral LL; Pane F; Ciceri F; Nagler A; Mohty M;

Role of Age, Fitness and Concomitant Medications in CLL Patients Treated with Venetoclax in Blood

2020
AOU Città della Salute di Torino

Frustaci AM; Biagi A; Chiarenza A; Coscia M; Ciolli S; Laurenti L; Sportoletti P; Reda G; Varettoni M; Mauro FR; Murru R; Baratè C; Greco A; Borella C; Zamprogna G; Martino EA; Vitale C; Morelli F; Fresa A; Guarente V; Noto A; Postorino M; Cairoli R; Montillo M; Del Poeta G; Tedeschi A;

Do Age, Fitness and Concomitant Medications Influence Management and Outcomes of CLL Patients Treated with Ibrutinib? in Blood

2020
AOU Città della Salute di Torino

Tedeschi A; Frustaci AM; Mauro FR; Chiarenza A; Coscia M; Ciolli S; Reda G; Laurenti L; Varettoni M; Murru R; Baratè C; Sportoletti P; Greco A; Borella C; Rossi V; Deodato M; Biagi A; Curto Pelle A; Lapietra G; Vitale C; Morelli F; Cassin R; Fresa A; Flospergher E; Postorino M; Di Prima A; Cairoli R; Di Raimondo F; Montillo M; et alii...

Efficacy and Safety of Front-Line Venetoclax and Rituximab (VenR) for the Treatment of Young Patients with Chronic Lymphocytic Leukemia and an Unfavorable Biologic Profile. Preliminary Results of the Gimema Study ‘Veritas‘ in Blood

2020
AOU Città della Salute di Torino

Mauro FR; Reda G; Arena V; Trentin L; Coscia M; Sportoletti P; Laurenti L; Gaidano G; Marasca R; Orsucci L; Murru R; Stelitano C; Ilariucci F; Mannina D; Massaia M; Rigolin GM; Scarfo L; Marchetti M; Levato L; Tani M; Arcari A; Musuraca G; Deodato M; Galieni P; Califano C; Gottardi D; Liberati AM; Pietrasanta D; Molica S; et alii...

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia in Blood

2020
AOU Città della Salute di Torino

Brandao LR; Tartakovsky I; Albisetti M; Bomgaars L; Chalmers E; Mitchell L; Luciani M; Saracco P; Felgenhauer J; Lvova O; Simetzberger M; Sun Z; Gergei I; Brueckmann M; Halton J;

HORIZON (OP-106): Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics-Subgroup Analysis in Blood

2020
AOU Città della Salute di Torino

Mateos M-V; Oriol A; Larocca A; Blade Creixenti J; Cavo M; Rodríguez-Otero P; Leleu X; Norkin M; Nadeem O; Hiemenz JW; Hassoun H; Touzeau C; Amor AA; Paner A; Maisel C; Mazumder A; Raptis A; Puig N; Harmenberg J; Gustavsson B; Thuresson M; Richardson PG;

Predictive Factors for Overall Survival in Chronic Myeloid Leukemia Patients: An Analysis By the Gimema Cml Italian Study in Blood

2020
AOU Città della Salute di Torino
AO Ordine Mauriziano

Ciccone G; Saglio G; Pane F; Foà R; Baccarani M; Martino B; Luciano L; Pizzuti M; Gozzini A; Scortechini AR; Albano F; Bergamaschi M; Capodanno I; Patriarca A; Fava C; Rege Cambrin G; Sorà F; Galimberti S; Bocchia M; Binotto G; Reddiconto G; Guarini A; Maggi A; Sanpaolo G; De Candia MS; Giai V; Abruzzese E; Miggiano MC; Falzetti F; et alii...

Brentuximab Vedotin As Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T-Cell Lymphoma Patients: A Phase 2 Study of the Fondazione Italiana Linfomi in Blood

2020
AOU Città della Salute di Torino

Stefoni V; Corradini P; Orsucci L; Volpetti S; Argnani L; Dodero A; Pellegrini C; Zinzani PL;

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT in Blood

2020
AOU Città della Salute di Torino

Devillier R; Galimard J-E; Labopin M; Blaise D; Angelucci E; Castagna L; Pavlu J; Socie G; Martino M; Stoelzel F; Bug G; Chalandon Y; Bruno B; Potter V; Brissot E; Savani BN; Nagler A; Mohty M;

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial in Blood

2020
AOU Città della Salute di Torino

Varettoni M; Ferrero S; Picone C; Gilestro M; Puig N; Marcheselli L; Dogliotti I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Jiménez C; Zibellini S; Drandi D; Candido C; Ferrante M; Fabbri N; Cavallo F; Arcaini L; Boccadoro M; Garcia-Sanz R; et alii...

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study. in Blood / Blood. 2019 Sep 5;134(10):798-801. doi: 10.1182/blood.2019001088. Epub 2019 Jul 10.

2019
AOU Città della Salute di Torino
ASL Città di Torino

Luminari S; Merli M; Rattotti S; Tarantino V; Marcheselli L; Cavallo F; Varettoni M; Bianchi B; Merli F; Tedeschi A; Cabras G; Re F; Visco C; Torresan Delamain M; Cencini E; Spina M; Ferrero S; Ferrari A; Deodato M; Mannina D; Annibali O; Rago A; Orsucci L; Defrancesco I; Frigeni M; Cesaretti M; Arcaini L;

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. in Blood / Blood. 2019 Nov 14;134(20):1708-1711. doi: 10.1182/blood.2019001617.

2019
AOU Città della Salute di Torino

d'Amore ESG; Motta G; Borchiellini A; Rambaldi A; Passamonti F; Lucchini E; Carli G; Santi RM; Volpetti S; Quaresimini G; Merli M; Romano A; Valeri F; Rodeghiero F; Visco C; Ruggeri M;

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies. in Blood / Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19.

2019
AOU Città della Salute di Torino

Bergaggio E; Riganti C; Garaffo G; Vitale N; Mereu E; Bandini C; Pellegrino E; Pullano V; Omedè P; Todoerti K; Cascione L; Audrito V; Riccio A; Rossi A; Bertoni F; Deaglio S; Neri A; Palumbo A; Piva R;

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. in Blood / Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7.

2019
AOU Città della Salute di Torino

Klanova M; Sehn LH; Bence-Bruckler I; Cavallo F; Jin J; Martelli M; Stewart D; Vitolo U; Zaja F; Zhang Q; Mattiello F; Sellam G; Punnoose EA; Szafer-Glusman E; Bolen CR; Oestergaard MZ; Fingerle-Rowson GR; Nielsen T; Trneny M;

Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 Study in Patients with Relapsed/Refractory Multiple Myeloma Refractory to Pomalidomide and/or Daratumumab in Blood

2019
AOU Città della Salute di Torino

Mateos M-V; Oriol A; Larocca A; Rodriguez Otero P; Bladé J; Cavo M; Hassoun H; Leleu X; Amor AA; Maisel C; Paner A; Harmenberg J; Byrne C; Thuresson S; Zubair H; Richardson PG;

Outcome of Two Loci Mismatched (?6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study in Blood

2019
AOU Città della Salute di Torino

Nagler A; Labopin M; Bruno B; Rambaldi A; Pioltelli P; La Nasa G; Socie G; Mielke S; Ruggeri M; Saccardi R; Platzbecker U; Finke J; Ruggeri A; Savani BN; Mohty M;

Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study in Blood

2019
AOU Città della Salute di Torino

Hungria VTM; Lee HC; Abonour R; Rifkin RM; Terpos E; Leleu X; Costello CL; van Rhee F; Weisel KC; Puig N; Berdeja JG; Cook G; Usmani SZ; Thompson MA; Boccadoro M; Zonder JA; Spencer A; Hajek R; Fanning SR; Boyd K; Omel J; Armour M; Morgan KE; Patel RS; Carlson GL; Ferrari RH; Stull DM; Ren K; Cherepanov D; et alii...

Expression of the Tigit/CD226/CD155 Receptors/Ligand System in Chronic Lymphocytic Leukemia in Blood

2019
AOU Città della Salute di Torino

Arruga F; Guerra G; Baev D; Hoofd C; Coscia M; D'Arena GF; Gaidano G; Furman RR; Deaglio S;

Preliminary Results from CPX-351 Italian Compassionate Use Program Show High Response Rate and Good Tolerability in Poor Prognosis AML Patients in Blood

2019
AOU Città della Salute di Torino

Guolo F; Minetto P; Fianchi L; Rondoni M; Daghia G; D'Ardia S; Morselli M; Pasciolla C; Pavesi F; Scappini BM; Lanza F; Gobbi M; Pagano L; Ferrara F; Lemoli RM;

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma in Blood

2019
AOU Città della Salute di Torino

Novo M; Sidiqi MH; Paludo J; Gandhi S; Kubusek J; Truong T; Hayne J; Ansell SM; Bennani NN; Villasboas JC; Nedved A; Lange G; Brandes E; Alkhateeb HB; Dingli D; Hayman SR; Kapoor P; Kenderian SS; Kourelis T; Kumar SK; Shah MV; Siddiqui M; Warsame RM; Johnston P; Lin Y;

Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Elderly Patients with Relapsed/Refractory Multiple Myeloma: Icaria-MM Subgroup Analysis in Blood

2019
AOU Città della Salute di Torino

Schjesvold FH; Richardson PG; Attal M; Facon T; Alegre A; Spencer A; Jurczyszyn A; Sunami K; Frenzel L; Min C-K; Le-Guennec S; Campana F; van de Velde H; Bensfia S; Bringhen S;

The MP0250-CP201 Mirror Study: A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs in Blood

2019
AOU Città della Salute di Torino

Grz??ko N; Knop S; Goldschmidt H; Raab MS; Dürig J; Bringhen S; D'Agostino M; Gamberi B; Rivolti E; Vacca A; Ria R; Jurczyszyn A; Castellano Acosta J; Lang D; Lemaillet G; Sudhir B; Szarejko M;

The Addition of Bortezomib to R-DHAP Does Not Improve the Response Pre-Stem Cell Transplantation Compared to Standard R-DHAP in Young Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results of the Phase II Randomized Trial FIL-VERAL12 of the Fondazione Italiana Linfomi in Blood

2019
AOU Città della Salute di Torino

Chiappella A; Balzarotti M; Monagheddu C; Cavallo F; Cabras MG; Zanni M; Califano C; Re F; Congiu AG; Corradini P; Olivieri A; Liberati AM; Volpetti S; Michieli M; Tucci A; Tani M; Nassi L; Mazza R; Novo M; Pileri SA; Ciccone G; Vitolo U;

Waldenström Macroglobulinemia in Young Patients Treated in the Modern Era: A Multi-Institutional Italian Study in Blood

2019
AOU Città della Salute di Torino

Varettoni M; Ferrari A; Tedeschi A; Ferretti VV; Rizzi R; Motta M; Piazza F; Merli M; Benevolo G; Visco C; Laurenti L; Del Fabro V; Abbadessa A; Klersy C; Rattotti S; Deodato M; Greco C; Corbingi A; Luminari S; Arcaini L;

Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma in Blood

2019
AOU Città della Salute di Torino

Moreau P; Harrison S; Cavo M; De La Rubia J; Popat R; Gasparetto C; Hungria VTM; Salwender H; Suzuki K; Kim I; Gay F; Mikala G; Punnoose EA; Hong W-J; Sood A; Jalaluddin M; Ross JA; Ward JE; Maciag PC; Kumar SK;

Impact of Bone Marrow Fibrosis Grade in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis. a Study of the Mysec Group in Blood

2019
AOU Città della Salute di Torino

Mora B; Rumi E; Guglielmelli P; Maffioli M; Barraco D; Rambaldi A; Caramella M; Komrokji RS; Gotlib J; Kiladjian J-J; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Uccella S; Siracusa C; Barbui T; Iurlo A; Bertù L; Merli M; Cazzola M; Vannucchi AM; Passamonti F;

A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group in Blood

2019
AOU Città della Salute di Torino

Caglayan C; Dixon J; Wall A; Salles GA; Hoster E; Hiddemann W; Herold M; Morschhauser F; Sebban C; Hagenbeek A; Marcus R; Hochster H; Rummel MJ; Kimby E; Vitolo U; Peterson BA; Gyan E; Ladetto M; Foussard CY; Ghielmini M; Nielsen TG; Foon K; Shi Q; Flowers CR;

Impact of Comorbidities and Body Mass Index in Patients with Polycythemia Vera: A PV-NET Real World Study in Blood

2019
AOU Città della Salute di Torino

Benevolo G; Elli EM; Latagliata R; Tiribelli M; Heidel FH; Cavazzini F; Bonifacio M; Crugnola M; Binotto G; D'Addio A; Tieghi A; Bergamaschi M; Caocci G; Polverelli N; Diral E; Beggiato E; Auteri G; Catani L; Sutto E; Griguolo D; Codeluppi K; Carmosino I; Cuneo A; Semenzato G; Krampera M; Lanza F; Lemoli RM; Cavo M; Bartoletti D; et alii...

Definition and Validation of the New Elderly Prognostic Index (EPI) for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Geriatric and Clinical Assessment: Results of the Prospective “Elderly Project” on 1353 Patients By the Fondazione Italiana Linfomi in Blood

2019
AOU Città della Salute di Torino

Spina M; Merli F; Puccini B; Cavallo F; Cabras MG; Fabbri A; Angrilli F; Zilioli VR; Marino D; Balzarotti M; Ladetto M; Cox MCC; Petrucci L; Arcari A; Gini G; Chiappella A; Hohaus S; Musuraca G; Merli M; Sartori R; Nassi L; Tani M; Re F; Flenghi L; Molinari AL; Kovalchuk S; Bottelli C; Ferrero S; Dessì D; et alii...

Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making in Blood

2019
AOU Città della Salute di Torino

Soverini S; Martelli M; Bavaro L; De Benedittis C; Iurlo A; Galimberti S; Pregno P; Bonifacio M; Lunghi F; Castagnetti F; Gugliotta G; Rosti G; Tiribelli M; Velotta V; Stagno F; Russo Rossi A; D'Adda M; Baratè C; Crugnola M; Luciano L; Laginestra MA; Corner AS; Maar D; Percesepe A; Pileri S; Pane F; Saglio G; Baccarani M; Martinelli G; et alii...

Concomitant Treatment with Ruxolitinib and Deferasirox in the Management of Iron Overload in Patients with Myelofibrosis: A Multicenter Italian Experience in Blood

2019
AOU Città della Salute di Torino

Elli EM; Di Veroli A; Iurlo A; Carmosino I; Benevolo G; Abruzzese E; Bonifacio M; Sutto E; Polverelli N; Caramella M; Cilloni D; Tiribelli M; Caocci G; Crisà E; Porrini R; Renso R; Markovic U; Cattaneo D; Biale L; Ansuinelli M; Trawinska MM; Scaffidi L; Breccia M; Gambacorti-Passerini C; Palumbo GA; Latagliata R;

A Prognostic Model Integrating PET-Derived Quantitative Parameters and Image Texture Analyses Using Radiomics in a Large Prospective Phase III Trial, GOYA in Blood

2019
AOU Città della Salute di Torino

Kostakoglu L; Berchialla P; Dalmasso F; Pierce LA; Vitolo U; Martelli M; Sehn LH; Trn?ný M; Nielsen TG; Bolen CR; Sahin D; Lee C; El-Galaly TCC; Mattiello F; Kinahan PE; Chauvie S;

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel) in Blood

2019
AOU Città della Salute di Torino

Melody M; Gandhi S; Abdel Rahman Z; Lengerke Diaz PA; Gannon N; Rosenthal AC; Truong T; Novo M; Brandes E; Lange G; Estby B; Johnston P; Ansell SM; Bennani NN; Paludo J; Villasboas J; Ayala E; Tun HW; Murthy HS; Roy V; Foran JM; Castro JE; Lin Y; Kharfan-Dabaja MA;

Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis in Blood

2019
AOU Città della Salute di Torino

Milani P; Fazio F; Basset M; Berno T; Larocca A; Foli A; Riva M; Oliva S; Ripepi J; Nuvolone M; Petrucci MT; Merlini G; Palladini G;

Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220) in Blood

2019
AOU Città della Salute di Torino

Lonial S; Amatangelo M; Popat R; Minnema MC; Zonder JA; Larsen J; Oriol Rocafiguera A; Campagnaro EL; Rodriguez Otero P; Badros AZ; Siegel DS; Jagannath S; Bringhen S; Gironella M; Kaiser MF; Cook G; Gamberi B; Sonneveld P; Nguyen TV; Chen MS; Homan T; Bjorklund CC; Wang M; Pierceall WE; Bensmaine A; Thakurta A; Peluso T; Van De Donk NWCJ;

Aurora Kinase a/MDM2-Mediated SETD2 Loss of Function in Chronic Myeloid Leukemia Patients in Blast Crisis Can be Therapeutically Targeted Inducing Apoptotic Cell Death in a Caspase-Dependent Way in Blood

2019
AOU Città della Salute di Torino

Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Gugliotta G; Castagnetti F; Rosti G; Fontana MC; Bruno S; Dan E; Sinigaglia B; Iurlo A; Orofino N; Abruzzese E; Salvucci M; Pregno P; Gozzini A; Crugnola M; Albano F; Bonifacio M; Calistri E; Tiribelli M; Binotto G; Imovilli A; Trabacchi E; Galimberti S; Baratè C; Tenti E; et alii...

Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study in Blood

2019
AOU Città della Salute di Torino

Chiappella A; Witzig TE; Cocks K; Greenwood M; Williams A; Scott DW; Gascoyne RD; Yamamoto K; Jurczak W; Özcan M; Belada D; Bergua Burgues JM; Piazza F; Visco C; Musuraca G; Margunato-Debay S; Czuczman M; Zhai M; Braverman J; Vitolo U; Nowakowski G;

Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study in Blood

2019
AOU Città della Salute di Torino

Cavallo F; Follows GA; Goy A; Vermaat J; Casasnovas R-O; Lavee O; Maerevoet M; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill BT; Jaeger U; Sancho J-M; Schuster MW; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Joshi A; Shah J; et alii...

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study in Blood

2019
AOU Città della Salute di Torino

Younes A; Burke JM; Cheson BD; Diefenbach C; Ferrari S; Hahn UH; Hawkes EA; Khan C; Lossos IS; Musuraca G; Tani M; Vitolo U; Yuen SLS; Raval A; Shivhare MR; Nielsen TG; Sellam G; Sharman JP;

Impact of Systematic Pharmacokinetic (PK) Profiles in a Cohort of 29 Patients Treated with Conventional and Extended-Half Life (EHL) Products in Blood

2019
AOU Città della Salute di Torino

Ceglie T; Pollio B; Ricca I; Messina M; Linari C; Pagliarino M;

Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience in Blood

2019
AOU Città della Salute di Torino

Novo M; Nowakowski G; Micallef I; King RL; Spinner R; Ristow KM; Habermann TM; Johnston P;

Clinical Outcomes Under Hydroxyurea and Impact of ELN Responses in Patients with Polycythemia Vera: A PV-NET Real World Study in Blood

2019
AOU Città della Salute di Torino

Palandri F; Elli EM; Benevolo G; Tiribelli M; Bonifacio M; Tieghi A; Cavazzini F; Palumbo GA; Heidel FH; Crugnola M; Binotto G; D'Addio A; Polverelli N; Bergamaschi M; Caocci G; Markovic U; Auteri G; Catani L; Di Pietro C; Diral E; Scaffidi L; Griguolo D; Codeluppi K; Cuneo A; Semenzato G; Krampera M; Lanza F; Lemoli RM; Breccia M; et alii...

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor in Blood

2019
AOU Città della Salute di Torino

Pollio B; Messina M; Ricca I; Pagliarino M; Ramenghi U; Coppola A; Castiglione A; Ciccone G; Ceglie T; Mondino A; Tavormina P; Linari C;

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide in Blood

2019
AOU Città della Salute di Torino

Lia G; Di Vito C; Tapparo M; Bruno S; Zaghi E; Calvi M; Brunello L; Mariotti J; Comba L; Giaccone L; Fascì M; Boccadoro M; Evangelista A; Castagna L; Camussi G; Mavilio D; Bruno B;

Euroclonality-NGS DNA Capture Panel for Integrated Analysis of IG/TR Rearrangements, Translocations, Copy Number and Sequence Variation in Lymphoproliferative Disorders in Blood

2019
AOU Città della Salute di Torino

Stewart P; Gazdova J; Darzentas N; Wren D; Proszek P; Fazio G; Songia S; Alcoceba M; Sarasquete ME; Villarese P; van der Klift MY; Heezen K; McCafferty N; Pal K; Catherwood M; Kim CS; Srivastava S; Hodges E; Stamatopoulos K; Klapper W; Ferrero S; van den Brand M; Cazzaniga G; Davi F; Garcia-Sanz R; Groenen P; Macintyre E; Brüggemann M; Pott C; et alii...

Osteoclast-Induced Immunosuppression Occurs through Dysregulation of Immune Checkpoint Axes in Multiple Myeloma in Blood

2019
AOU Città della Salute di Torino

Mukaihara K; D'Agostino M; Panaroni C; Fulzele K; Mori T; Siu KT; Chattopadhyay S; Raje N;

Risk Factors for Progression to Blast Phase and Outcome in 589 Patients with Myelofibrosis Treated with Ruxolitinib: Real-World Evidence in Blood

2019
AOU Città della Salute di Torino

Palandri F; Breccia M; Tiribelli M; Polverelli N; Benevolo G; Tieghi A; Binotto G; Bonifacio M; Martino B; Iurlo A; Elli EM; Abruzzese E; Bergamaschi M; Sgherza N; Cavazzini F; Crugnola M; Bosi C; Isidori A; Heidel FH; Markovic U; Auteri G; Catani L; Latagliata R; Griguolo D; Codeluppi K; Cattaneo D; Trawinska MM; Bartoletti D; Krampera M; et alii...

Cancer and E-Health: Evidences and Contributes Emerging from a Social Network Page Dedicated to Onco-Hematological Diseases in Blood

2019
AOU Città della Salute di Torino

Botto R; Prencipe M; Ieraci V; Vitolo U; Torta R;

ABVD Versus Escalated Beacopp in Advanced Stage Hodgkin's Lymphoma: Results from a Retrospective, Multicenter European Study in Blood

2019
AOU Città della Salute di Torino

Mondello P; Dogliotti I; Bohn J-P; Cavallo F; Ferrero S; Botto B; Cerchione C; Nappi D; De Lorenzo S; Martinelli G; Wolf D; Loseto G; Cuzzocrea S; Willenbacher W; Mian M;

Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs in Blood

2019
ASL Asti
AOU Città della Salute di Torino

Vitale C; Salvetti C; Griggio V; Scamuffa MC; Zamprogna G; Visentin A; Cassin R; Laurenti L; Murru R; Rivela P; Marchetti M; Gentile M; Pennese E; Reda G; Trentin L; Tedeschi A; Mauro FR; Foà R; Boccadoro M; Coscia M;

Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls in Blood

2019
ASL Asti
AOU Città della Salute di Torino

De Stefano V; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Pérez-Encinas M; Lunghi F; Angona A; Fox ML; et alii...

Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era in Blood

2019
AOU Città della Salute di Torino

Boddicker NJ; Maurer MJ; Larson MC; Allmer C; Slager SL; Habermann TM; Chen ST; Villarraga HR; Herrmann J; Thanarajasingam G; Castellino A; Nowakowski G; Inwards DJ; Cerhan JR; Thompson CA;

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06 in Blood

2019
AOU Città della Salute di Torino
AOU Alessandria

Caprioli C; Lussana F; Salmoiraghi S; Cavagna R; Buklijas K; Elidi L; Zanghì P; Michelato A; Delaini F; Oldani E; Ferrero D; Audisio E; Marmont F; Terruzzi E; De Paoli L; Cattaneo C; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei DG; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; Cortelezzi A; Cortelazzo S; Gianfaldoni G; et alii...

The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Baseline and after Treatment Based on HORIZON (OP-106) Study of Melflufen Plus Dexamethasone in Blood

2019
AOU Città della Salute di Torino

Richardson PG; Larocca A; Leleu X; Oriol A; Paner A; Rodriguez Otero P; Touzeau C; Amor AA; Maisel C; Mateos M-V; Mazumder A; Strang P; Öhman O; Harmenberg J; Zavisic S; Bladé J;

Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia in Blood

2019
AOU Città della Salute di Torino

Griggio V; Vitale C; Salvetti C; Mauro FR; Pietrasanta D; Vincelli ID; Scarfo L; Del Poeta G; Gaidano G; Gattei V; Foà R; Boccadoro M; Coscia M;

Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL) in Blood

2019
AOU Città della Salute di Torino

Kostakoglu L; Martelli M; Sehn LH; Trn?ný M; Vitolo U; Knapp A; Mattiello F; Nielsen TG; Sahin D; Sellam G; Ward C; Younes A;

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies in Blood

2019
AOU Città della Salute di Torino

Nowakowski G; Chiappella A; Hong F; Gascoyne RD; Scott DW; Macon WR; King RL; Amengual JE; Little RF; Leonard JP; Friedberg JW; Kostakoglu L; Jurczak W; Yamamoto K; Czuczman M; Russo J; Hudak K; Zhang J; Wade S; Witzig TE; Kahl BS; Vitolo U;

Patient-Level Meta-Analysis of End-of-Therapy PET-CR as a Surrogate Endpoint for PFS and OS in Patients with Previously Untreated DLBCL: Implications for Clinical Trial Design in Blood

2019
AOU Città della Salute di Torino

Berry D; Broglio K; Ward C; Mattiello F; Sahin D; Nielsen TG; McGlothlin A; Elliott C; Witzig TE; Sehn LH; Trn?ný M; Vitolo U; Martelli M; Kostakoglu L; Nowakowski G;

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study in Blood

2019
AOU Città della Salute di Torino

Dholaria B; Labopin M; Angelucci E; Ciceri F; Díez-Martín JL; Bruno B; Sica S; Koc Y; Gulbas Z; Schmid C; Blaise D; Carella AM; Visani G; Savani BN; Nagler A; Mohty M;

Preliminary Results of CML1214, a Survey on Ponatinib Compassionate Use in Italy By the Gimema CML Working Party in Blood

2019
AOU Città della Salute di Torino

Fava C; Dragani ME; Boggione P; Paoloni F; Luciano L; Gozzini A; Pregno P; Abruzzese E; Gambacorti-Passerini C; Specchia G; Elena C; Lunghi M; Pungolino E; Falzetti F; Galimberti S; Iurlo A; D'Arena G; Reddiconto G; Fozza C; Bergamaschi M; Crea E; Saglio G; Rege Cambrin G;

EARLY STAGE Follicular Lymphoma: First Results of the FIL “Miro” Study, a Multicenter Phase II Trial Combining Local Radiotherapy and MRD-Driven Immunotherapy in Blood

2019
AOU Città della Salute di Torino

Pulsoni A; Tosti ME; Ferrero S; Luminari S; Liberati AM; Cenfra N; Renzi D; Zanni E; Boccomini C; Ferreri AJ; Rattotti S; Zilioli VR; Bernuzzi P; Bolis S; Musuraca G; Nassi L; Perrone T; Stelitano C; Anastasia A; Corradini P; Partesotti G; Re F; Cencini E; Mannarella C; Mannina D; Molinari AL; Tani M; Annechini G; Assanto GM; et alii...

The Locommotion Study (MMY4001): A Prospective, Multinational Study of Real-Life Current Standards of Care in Patients with Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including PI, IMiD, and CD38 Monoclonal Antibody Treatment and Documented Disease Progression in Blood

2019
AOU Città della Salute di Torino

Delforge M; Moreau P; Mateos M-V; De Stefano V; Weisel K; San-Miguel J; Einsele H; Facon T; Boccadoro M; Goldschmidt H; Cavo M; Rosinol L; Kaiser MF; Gay F; Scheid C; Broyl A; Van De Donk NWCJ; Rodriguez P; Potamianou A; Sakabedoyan C; Strulev V; Nesheiwat T; Bergmans P; Rizvi S; Pilatowicz A; Sonneveld P;

Dose Optimization in Elderly CML Patients Treated with Bosutinib after Intolerance or Failure of First-Line Tyrosine Kinase Inhibitors in Blood

2019
AOU Città della Salute di Torino

Castagnetti F; Gugliotta G; Bocchia M; Trawinska MM; Capodanno I; Bonifacio M; Rege Cambrin G; Crugnola M; Binotto G; Elena C; Lucchesi A; Bergamaschi M; Albano F; Luciano L; Sorà F; Lunghi F; Stagno F; Pregno P; Iurlo A; Scortechini AR; Cedrone M; Spadano R; Trabacchi E; Lunghi M; Spinosa G; Ferrero D; Pini M; Rapezzi D; Nocilli L; et alii...

Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma in Blood

2019
AOU Città della Salute di Torino

Sehn LH; Martelli M; Trn?ný M; Liu W; Bolen CR; Knapp A; Sahin D; Sellam G; Vitolo U;

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics in Blood

2019
AOU Città della Salute di Torino

Muccio VE; Gilestro M; Saraci E; Capra A; Costa A; Ruggeri M; Caltagirone S; Oddolo D; Mussatto C; Musto P; Pantani L; Pavone V; Ronconi S; Vincelli ID; Cafro AM; Cellini C; Innao V; Piro E; Gay F; Boccadoro M; Omedé P;

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. in Blood / Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4.

2018
AOU Città della Salute di Torino

van Rhee F; Voorhees P; Dispenzieri A; Fosså A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK; Partridge HL; Mukherjee S; Shilling D; Stone K; Greenway A; Ruth J; Lechowicz MJ; Chandrakasan S; Jayanthan R; Jaffe ES; Leitch H; Pemmaraju N; Chadburn A; Lim MS; Elenitoba-Johnson KS; Krymskaya V; Goodman A; Hoffmann C; Zinzani PL; et alii...

Unrelated donor vs HLA-haploidentical ?/? T-cell- and B-cell-depleted HSCT in children with acute leukemia. in Blood / Blood. 2018 Dec 13;132(24):2594-2607. doi: 10.1182/blood-2018-07-861575. Epub 2018 Oct 22.

2018
AOU Città della Salute di Torino

Pagliara D; Locatelli F; Fagioli F; Boghen S; Casazza G; Rabusin M; Balduzzi A; Ripaldi M; Del Bufalo F; Cesaro S; Favre C; Tumino M; Barberi W; Prete A; Perotti C; Gallina AM; Bertaina V; Lanino E; Saglio F; Buldini B; Zecca M; Algeri M; Sacchi N; Bertaina A;

The engineered MIPI (E-MIPI), a candidate data-mining based mantle cell lymphoma prognostic index developed from the dataset of the fondazione italiana linfomi (FIL) MCL0208 phase iii trial in Blood

2018
AOU Città della Salute di Torino
AOU Alessandria

Zaccaria GM; Ferrero S; Passera R; Evangelista A; Loschirico M; Dogliotti I; Ghislieri M; Genuardi E; Bomben R; Gattei V; Ciccone G; Tani M; Gaidano G; Volpetti S; Cabras MG; Di Renzo N; Merli F; Vallisa D; Spina M; Pascarella A; Latte G; Patti C; Pozzato G; Fabbri A; Cortelazzo S; Ladetto M;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Graft-versus-leukemia effect after haplo-identical stem cell transplantation with post-transplant cyclophosphamide in patients with AML-no association with graft-versus-host disease: A study on behalf of the acute leukemia working party of EBMT in Blood

2018
AOU Città della Salute di Torino

Shimoni A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Gülbas Z; Diez-Martin JL; Bruno B; Castagna L; Martino M; Rovira M; Mohty M; Nagler A;

Busulfan, cyclophosphamide and melphalan as conditioning regimen for pediatric patients with aml in 1st or 2nd CR: A retrospective analysis from the aieop HSCt registry in Blood

2018
AOU Città della Salute di Torino

Ruggeri A; Zecca M; Fagioli F; Balduzzi A; Algeri M; Tumino M; Ripaldi M; Masetti R; Saglio F; Rovelli A; Locatelli F;

Prognostic impact of germ-line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) single nucleotide polymorphisms in lymphoma patients treated with obinutuzumab or rituximab in combination with chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials in Blood

2018
AOU Città della Salute di Torino

Strefford JC; Nowicka M; Hargreaves C; Iriyama C; Latham KV; Ganderton R; Parker H; Potter KN; Knapp A; Mir F; Rose-Zerilli MJJ; Burton C; Hiddemann W; Klapper W; Sehn LH; Vitolo U; Martelli M; Davies A; Cragg MC; Oestergaard MZ;

Infections in patients with lymphoproliferative diseases treated with target therapy. Italian multicentric retrospective study seifem 2017 in Blood

2018
AOU Città della Salute di Torino

Nadali G; Marchesini G; Facchinelli D; Farina F; Tisi MC; Lessi F; Marchesi F; Cattaneo C; Candoni A; Fanci R; Prezioso L; Verga L; Laurenti L; Trastulli F; Picardi M; Del Principe MI; Silva R; Busca A;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in Blood

2018
ASL Asti
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino

Santini V; Gioia DM; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Boveri E; Ponzoni M; Gianelli U; Della Porta MG;

Whole genome sequencing reveals recurrent structural driver events in peripheral T-cell lymphomas not otherwise specified in Blood

2018
AOU Città della Salute di Torino

Maura F; Bolli N; Leongamornlert D; Carniti C; Dodero A; Abascal F; Testi A; Rodriguez-Martin B; Pellegrinelli A; Biancon G; Magni M; Chiappella A; Martincorena I; Tubio JMC; Pruneri G; Campbell PJ; Corradini P;

Prognostic relevance of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ratio (LMR) in newly diagnosed advanced-stage Hodgkin lymphoma patients treated up-front with a pet-2 risk adapted protocol in Blood

2018
AOU Città della Salute di Torino

Romano A; Di Raimondo F; Pavoni C; Tarella C; Viviani S; Rossi A; Patti C; Picardi M; Cantonetti M; Nasa GL; Trentin L; Bolis S; Zoli V; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis GE; Zanotti R; Gini G; Ferreri AJM; Viero P; Biggi A; Gianni AM; Gallamini A; Rambaldi A;

High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: The italian experience on behalf of GITMO, IBMDR and AIBT in Blood

2018
AOU Città della Salute di Torino

Picardi A; Sacchi N; Miotti V; Lorentino F; Oldani E; Rambaldi A; Sessa M; Bruno B; Cerno M; Bernasconi P; Vago L; Arcese W; Benedetti F; Pioltelli P; Farina L; Saporiti G; Chiusolo P; Zallio F; Fagioli F; Papalinetti G; Borghero C; Carella AM; Narni F; Russo D; Olivieri A; Lamparelli T; Specchia G; Guidi S; Iori AP; et alii...

Bone marrow biopsy impacts response assessment in a minority of patients with follicular lymphoma and diffuse large B-cell lymphoma treated with immunochemotherapy: Results from the randomized phase iii gallium and GOYA trials in Blood

2018
AOU Città della Salute di Torino

Rutherford SC; Herold M; Hiddemann W; Kostakoglu L; Marcus R; Martelli M; Sehn LH; Trotman J; Vitolo U; Nielsen T; Mattiello F; Sahin D; Sellam G; Martin P;

Sparing anti-bacterial prophylaxis in acute myeloid leukemia during post induction aplasia does not impact on bacteriemiae incidence and early death: A retrospective single center study in Blood

2018
ASL Torino 4
AOU Città della Salute di Torino

Frairia C; Urbino I; Audisio E; Aydin S; D'Ardia S; Emanuela M; Iovino G; Nicolino B; Vitolo U;

High efficacy of lenalidomide plus R-CHOP (R2CHOP) combination in first line treatment of activated B-cell (ABC) ZDLBCL defined using gene-expression prophyling: A combined analysis from two phase 2 trials in Blood

2018
AOU Città della Salute di Torino

Castellino A; Chiappella A; Laplant B; Pederson LD; Inghirami G; Gaidano G; MacOn WR; Tucci A; King RL; Congiu AG; Habermann TM; Witzig TE; Vitolo U; Nowakowski GS;

Safety and efficacy of atezolizumab in combination with rituximab plus chop in previously untreated patients with diffuse large B-cell lymphoma (DLBCL): Primary analysis of a phase I/II study in Blood

2018
AOU Città della Salute di Torino

Younes A; Burke JM; Cheson B; Diefenbach C; Ferrari S; Hahn U; Hawkes E; Khan C; Lossos IS; Musuraka G; Tani M; Vitolo U; Yuen S; Oestergaard MZ; Chitra S; Wenger M; Nielsen T; Sellam G; Sharman J;

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial. in Blood / Blood. 2017 Apr 20;129(16):2328-2330. doi: 10.1182/blood-2017-01-764258. Epub 2017 Mar 6.

2017
AOU Città della Salute di Torino

Stefoni V; Argnani L; Cabras MG; Salvi F; Di Rocco A; Chiappella A; Pellegrini C; Zinzani PL;

Impact of bortezomib-or lenalidomide-based induction treatment on high risk cytogenetic transplant-ineligible patients with newly diagnosed multiple myeloma enrolled in the gimema-MM-03-05 and EMN01 trials in Blood

2017
AOU Città della Salute di Torino

Larocca A; Offidani M; Ciccone G; Guglielmelli T; Cangialosi C; Salvini M; Corradini P; De Paoli L; Patriarca F; Dore F; Belotti A; D'Agostino M; Ferrara F; Oddolo D; Centurioni R; Ciambelli F; Spada S; Vincelli DI; Cavo M; Giuliani N; Bosi A; Conticello C; Ria R; Petrucci MT; Boccadoro M;

National early warning score (NEWS) and quick sequential (Sepsis-Related) organ failure assessment (qSOFA) validation in AML patient during febrile neutropenia in Blood

2017
AOU Città della Salute di Torino

Nicolino B; Vitolo U; Audisio E; D'Ardia S; Frairia C; Iovino G; Evangelista A; Ciccone G; Aydin S;

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. in Blood / Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Guglielmelli T; Ledda A; Zambello R; Ruggeri M; Maisnar V; Ciccone G; Conticello C; Pulini S; Bernardini A; Musolino C; Giuliani N; Gentili S; Pietrantuono G; De Paoli L; Falcone AP; Mina R; Patriarca F; Benevolo G; Offidani M; Bringhen S; Magarotto V; Montefusco V; Hajek R; Boccadoro M; Palumbo A;

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. in Blood / Blood. 2016 Jun 9;127(23):2833-40. doi: 10.1182/blood-2016-01-694604. Epub 2016 Apr 18.

2016
AOU Città della Salute di Torino

Jakubowiak A; Offidani M; Pégourie B; De La Rubia J; Garderet L; Laribi K; Bosi A; Marasca R; Laubach J; Mohrbacher A; Carella AM; Singhal AK; Tsao LC; Lynch M; Bleickardt E; Jou YM; Robbins M; Palumbo A;

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. in Blood / Blood. 2016 Jan 14;127(2):221-32. doi: 10.1182/blood-2014-12-614503. Epub 2015 Oct 13.

2016
AOU Città della Salute di Torino

Scarfò I; Pellegrino E; Mereu E; Kwee I; Agnelli L; Bergaggio E; Garaffo G; Vitale N; Caputo M; Machiorlatti R; Circosta P; Abate F; Barreca A; Novero D; Mathew S; Rinaldi A; Tiacci E; Serra S; Deaglio S; Neri A; Falini B; Rabadan R; Bertoni F; Inghirami G; Piva R;

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. in Blood / Blood. 2016 Apr 28;127(17):2101-12. doi: 10.1182/blood-2015-09-670729. Epub 2016 Feb 17.

2016
AOU Città della Salute di Torino

Schrappe M; Conter V; Rössig C; Barisone E; Caruso R; von Stackelberg A; Parasole R; Harbott J; Kremens B; Greiner J; Lo Nigro L; Ratei R; Kulozik AE; Basso G; Beier R; Bartram CR; Attarbaschi A; Silvestri D; Aricò M; Niggli F; Cazzaniga G; Locatelli F; Mann G; Biondi A; Valsecchi MG; Zimmermann M; Stanulla M; Möricke A;

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AOU Città della Salute di Torino
AOU Novara

Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...

How I treat fragile myeloma patients. in Blood / Blood. 2015 Nov 5;126(19):2179-85. doi: 10.1182/blood-2015-05-612960. Epub 2015 Aug 31.

2015
AOU Città della Salute di Torino

Larocca A; Palumbo A;

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. in Blood / Blood. 2015 Mar 26;125(13):2068-74. doi: 10.1182/blood-2014-12-615187. Epub 2015 Jan 27.

2015
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV;

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma. in Blood / Blood. 2015 Jan 15;125(3):449-56. doi: 10.1182/blood-2014-05-576256. Epub 2014 Nov 14.

2015
AOU Città della Salute di Torino

Sonneveld P; Asselbergs E; Zweegman S; van der Holt B; Kersten MJ; Vellenga E; van Marwijk-Kooy M; Broyl A; de Weerdt O; Lonergan S; Palumbo A; Lokhorst H;

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. in Blood / Blood. 2015 Jan 1;125(1):111-23. doi: 10.1182/blood-2014-07-589069. Epub 2014 Nov 3.

2015
AOU Città della Salute di Torino
AOU Novara

Wolberger C; Garcia JG; Gaidano G; Rizzi M; Wang T; Inghirami G; Rossi D; Maffei R; Vaisitti T; Coscia M; Arruga F; Mazzola F; Brusa D; Serra S; Audrito V; Raffaelli N; Deaglio S;

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. in Blood / Blood. 2015 Aug 20;126(8):950-6. doi: 10.1182/blood-2014-12-616474. Epub 2015 Jun 18.

2015
AOU Città della Salute di Torino

Ceriani L; Martelli M; Zinzani PL; Ferreri AJ; Botto B; Stelitano C; Gotti M; Cabras MG; Rigacci L; Gargantini L; Merli F; Pinotti G; Mannina D; Luminari S; Stathis A; Russo E; Cavalli F; Giovanella L; Johnson PW; Zucca E;

Eloquent-2 update: A phase 3, randomized, open-label study of elotuzumab in combination with lenalidomide/dexamethasone in patients with relapsed/refractory multiple myeloma-3-year safety and efficacy follow-up in Blood

2015
AOU Città della Salute di Torino

Dimopoulos MA; Lonial S; White D; Moreau P; Palumbo A; San Miguel J; Shpilberg O; Anderson KC; Grosicki S; Spicka I; Walter-Croneck A; Magen-Nativ H; Mateos M-V; Belch A; Reece D; Beksac M; Bleickhardt E; Poulart V; Katz J; Singhal AK; Richardson PG;

Elotuzumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma: 2-year follow-up in Blood

2015
AOU Città della Salute di Torino

Palumbo A; Offidani M; Pégourie B; De La Rubia J; Garderet L; Laribi K; Bosi A; Marasca R; Laubach JP; Mohrbacher A; Carella AM; Singhal AK; Lynch M; Jou Y-M; Jakubowiak A;

An ongoing multinational observational study in multiple myeloma (PREAMBLE): Preliminary report on patient survival in Blood

2015
AOU Città della Salute di Torino

Cook G; Cella D; Durie B; Goldschmidt H; Kuter D; Moreau P; Vij R; Davis C; Oukessou A; Zyczynski T; Popov S; Palumbo A;

Infection complications in 476 patients with newly diagnosed multiple myeloma treated with lenalidomide or bortezomib combinations in Blood

2015
AOU Città della Salute di Torino

Offidani M; Corvatta L; Bringhen S; Gentili S; Gay F; Maracci L; Boccadoro M; Leoni P; Palumbo A;

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. in Blood / Blood. 2014 Sep 11;124(11):1715-26. doi: 10.1182/blood-2014-02-558296. Epub 2014 Jul 18.

2014
AOU Città della Salute di Torino

Noris M; Galbusera M; Gastoldi S; Macor P; Banterla F; Bresin E; Tripodo C; Bettoni S; Donadelli R; Valoti E; Tedesco F; Amore A; Coppo R; Ruggenenti P; Gotti E; Remuzzi G;

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma. in Blood / Blood. 2014 Jun 26;123(26):4136-42. doi: 10.1182/blood-2013-12-546374. Epub 2014 May 15.

2014
AOU Città della Salute di Torino

San-Miguel J; Bladé J; Shpilberg O; Grosicki S; Maloisel F; Min CK; Polo Zarzuela M; Robak T; Prasad SV; Tee Goh Y; Laubach J; Spencer A; Mateos MV; Palumbo A; Puchalski T; Reddy M; Uhlar C; Qin X; van de Velde H; Xie H; Orlowski RZ;

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.

2014
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Caravita T; Tacchetti P; Oliva S; Montefusco V; Genuardi M; Benevolo G; Ciccone G; Gentilini F; Offidani M; Omedé P; Boccadifuoco L; Musto P; Magarotto V; Rossi D; Conticello C; Larocca A; Petrucci MT; Bringhen S; Sonneveld P; Palumbo A;

Gay F, Magarotto V, Crippa C, et al. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: Updated results. (Blood (2013) 122, 8 (1376-1383)) in Blood

2014
AOU Città della Salute di Torino

Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A;

A double-blind, multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal amphotericin B (AmBisome®) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) in Blood

2014
AOU Città della Salute di Torino

Cornely O; Leguay T; Maertens J; Castagnola C; Anagnostopoulos A; Allione B; Heussel CP; Donnelly JP; Agrawal SG; Garner W; Simcock C; Hawkins MJ; Goekbuget N;

Distinct DNA methylation and expression profiles underlie CMML responsiveness to decitabine and uncover novel mechanism of resistance in Blood

2014
AOU Città della Salute di Torino

Meldi K; Qin T; Buchi F; Micol J-B; Sotzen J; Masala E; Allione B; Gioia D; Poloni A; Lunghi M; Abdel-Wahab O; Santini V; Figueroa ME;

The impact of response on bone-directed therapy in patients with multiple myeloma. in Blood / Blood. 2013 Oct 24;122(17):2974-7. doi: 10.1182/blood-2013-04-498139. Epub 2013 Aug 23.

2013
AOU Città della Salute di Torino

Larocca A; Child JA; Cook G; Jackson GH; Russell N; Szubert A; Gregory WM; Brioli A; Owen RG; Drayson MT; Wu P; Palumbo A; Boccadoro M; Davies FE; Morgan GJ;

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. in Blood / Blood. 2013 Aug 22;122(8):1376-83. doi: 10.1182/blood-2013-02-483073. Epub 2013 Jun 17.

2013
AOU Città della Salute di Torino

Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A;

A simple score, based on geriatric assessment, improves prediction of survival, and risk of serious adverse events in elderly newly diagnosed multiple myeloma patients in Blood

2013
AOU Città della Salute di Torino

Larocca A; Bringhen S; Evangelista A; Offidani M; Ballanti S; Zaccaria A; Pescosta N; Montefusco V; De Rosa L; Carella AM; Baldini L; Aglietta M; Vincelli ID; Marasca R; Pezzati S; Tosi P; Cocito F; Grasso M; Fioritoni G; Pavone V; Musto P; Grammatico S; Omedè P; Gay F; Ciccone G; Boccadoro M; Palumbo A;

Retrospective analysis of 204 patients with polycythemia vera: the international working group for myeloproliferative neoplasm research and treatment (IWG-MRT) prognostic score is a good predictor of survival and prognosis in Blood

2013
AOU Città della Salute di Torino

Benevolo G; Crisà E; Nicolino B; Pregno P; Beggiato E; Evangelista A; Ferrero D; Godio L; Boccadoro M; Vitolo U;

Impact of bone marrow involvement on outcome of young patients with high-risk diffuse large B-cell lymphoma (DLBCL) treated in the phase III randomized trial (DLCL04) with rituximab dose-dense chemotherapy followed by intensified high-dose chemotherapy and autologous stem cell transplantation (HDC+ASCT) or standard rituximab dose dense chemotherapy: A study of the fondazione Italiana linfomi (FIL) in Blood

2013
AOU Città della Salute di Torino

Vitolo U; Chiappella A; Brusamolino E; Angelucci E; Rossi G; Carella AM; Evangelista A; Stelitano C; Balzarotti M; Merli F; Gaidano G; Gotti M; Pavone V; Rigacci L; Zaja F; Rusconi C; De Renzo A; Pinotti G; Pizzuti M; Spina M; Cantonetti M; Specchia G; Pregno P; Russo E; Tucci A; Cabras MG; Pileri SA; Levis A; Martelli M; et alii...

Maintenance therapy with lenalidomide significantly improved survival of yong newly diagnosed multiple myeloma patients in Blood

2013
AOU Città della Salute di Torino

Gay F; Cavallo F; Caravita T; Cavalli M; Nagler A; Montefusco V; Pogliani EM; Buttignol S; Zamagni E; Palladino C; Marcatti M; Musto P; Catalano L; Baraldi A; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Vallone LM; Ciccone G; Yehuda DB; Di Raimondo F; Hardan I; Boccadoro M; Palumbo A;

Paroxysmal nocturnal hemoglobinuria with budd-chiari syndrome treated with complement inhibitor eculizumab; a case report in Blood

2013
AOU Città della Salute di Torino

Valeri F; Borchiellini A; Schinco P; Boccadoro M;

Either combined-modality or radiotherapy alone provide favorable outcome in stage I-II mantle cell lymphoma: A report of 82 patients from the international lymphoma radiation oncology group (ILROG) in Blood

2013
AOU Città della Salute di Torino

Dabaja BS; Tsang R; Qi S; Allen P; Hodgson DC; Ricardi U; Hoppe RT; Ng A; Specht L; Li Y-X; Terezakis S; Constine L; Yahalom J;

Dysfunctional V?9V?2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. in Blood / Blood. 2012 Oct 18;120(16):3271-9. doi: 10.1182/blood-2012-03-417519. Epub 2012 Aug 29.

2012
AOU Città della Salute di Torino

Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M;

Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. in Blood / Blood. 2012 Oct 18;120(16):3222-8. doi: 10.1182/blood-2012-04-423095. Epub 2012 Aug 27.

2012
AOU Città della Salute di Torino

Benevolo G; Stacchini A; Spina M; Ferreri AJ; Arras M; Bellio L; Botto B; Bulian P; Cantonetti M; Depaoli L; Di Renzo N; Di Rocco A; Evangelista A; Franceschetti S; Godio L; Mannelli F; Pavone V; Pioltelli P; Vitolo U; Pogliani EM;

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. in Blood / Blood. 2012 Mar 1;119(9):2066-73. doi: 10.1182/blood-2011-06-359943. Epub 2012 Jan 10.

2012
AOU Città della Salute di Torino

Pregno P; Chiappella A; Bellò M; Botto B; Ferrero S; Franceschetti S; Giunta F; Ladetto M; Limerutti G; Menga M; Nicolosi M; Priolo G; Puccini B; Rigacci L; Salvi F; Vaggelli L; Passera R; Bisi G; Vitolo U;

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide in Blood

2012
AOU Città della Salute di Torino

Larocca A; Cavallo F; Bringhen S; Di Raimondo F; Falanga A; Evangelista A; Cavalli M; Stanevsky A; Corradini P; Pezzatti S; Patriarca F; Cavo M; Peccatori J; Catalano L; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Petrucci MT; Yehuda DB; Beggiato E; Di Toritto TC; Boccadoro M; Nagler A; Palumbo A;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;

Rituximab dose-dense chemotherapy followed by intensified high-dose chemotherapy and autologous stem cell transplantation (HDC+ASCT) significantly reduces the risk of progression compared to standard rituximab dose-dense chemotherapy as first line treatment in young patients with high-risk (AA-IPI 2-3) diffuse large B-cell lymphoma (DLBCL): Final results of phase III randomized trial DLCL04 of the fondazione Italiana linfomi (FIL) in Blood

2012
AOU Città della Salute di Torino

Vitolo U; Chiappella A; Brusamolino E; Angelucci E; Rossi G; Michele Carella A; Evangelista A; Stelitano C; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; Cascavilla N; D'Arco AM; Rusconi C; De Renzo A; Pinotti G; Spina M; Pregno P; Russo E; Gotti M; Tucci A; Cabras MG; Pileri SA; Levis A; Martelli M;

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma in Blood

2011
AOU Città della Salute di Torino

Giaccone L; Storer B; Patriarca F; Rotta M; Sorasio R; Allione B; Carnevale-Schianca F; Festuccia M; Brunello L; Omedè P; Bringhen S; Aglietta M; Levis A; Mordini N; Gallamini A; Fanin R; Massaia M; Palumbo A; Ciccone G; Storb R; Gooley TA; Boccadoro M; Bruno B;

The RacGAP ArhGAP15 is a master negative regulator of neutrophil functions in Blood

2011
AOU Città della Salute di Torino

Costa C; Germena G; Martin-Conte EL; Molineris I; Bosco E; Marengo S; Azzolino O; Altruda F; Ranieri VM; Hirsch E;

Prognostic value of serum ferritin, transferrin saturation and C-reactive protein at diagnosis in myelodysplastic syndrome patients: Analysis of patients from the MDS piedmont registry in Blood

2011
ASL Torino 4
AOU Città della Salute di Torino

Messa E; Gioia D; Bertassello C; Ciccone G; Evangelista A; Manuela C; Allione B; Cilloni D; Salvi F; Cametti G; Lunghi M; Ferrero D; Falco P; Bonferroni M; Saglio G; Levis A;

A phase I/II study of pomalidomide-cyclophosphamide-prednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide in Blood

2011
ASL Vercelli
AOU Città della Salute di Torino

Palumbo A; Larocca A; Carella AM; Rossi D; Montefusco V; Ferrari S; Santagostino A; Guglielmelli T; Galli M; Capaldi A; Giuliani N; Verde GL; Omedè P; Baldi I; Boccadoro M; Corradini P;

Rituximab followed by involved fields radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): Long term results in Blood

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ruella M; Filippi A; Russo ADI; Caracciolo D; Matteucci P; Magni M; Di Nicola M; Ricardi U; Montefusco V; Parvis G; Tarella C; Gianni AM; Devizzi L;

Final results of a multicenter phase II trial assessing the activity and efficacy of helicobacter pylori-eradicating antibiotic therapy as exclusive treatment for patients with stage I-II1 diffuse large b-cell lymphoma of the stomach (the HGL-1 trial) in Blood

2011
AOU Città della Salute di Torino

Govi S; Patti C; Raderer M; Andriani A; Caracciolo D; Guidetti A; Ilariucci F; Luminari S; Mulè A; Viale E; Arcidiacono PG; Ponzoni M; Ferreri AJM;

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients in Blood

2010
AOU Città della Salute di Torino

Bringhen S; Larocca A; Rossi D; Cavalli M; Genuardi M; Ria R; Gentili S; Patriarca F; Nozzoli C; Levi A; Guglielmelli T; Benevolo G; Callea V; Rizzo V; Cangialosi C; Musto P; De Rosa L; Liberati AM; Grasso M; Falcone AP; Evangelista A; Cavo M; Gaidano G; Boccadoro M; Palumbo A;

Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: A prospective, multicenter phase 3 study in Blood

2010
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Bruno B; Falcone AP; Liberati AM; Grasso M; Ria R; Pisani F; Cangialosi C; Caravita T; Levi A; Meloni G; Nozza A; Pregno P; Gabbas A; Callea V; Rizzo M; Annino L; De Stefano V; Musto P; Baldi I; Cavallo F; Petrucci MT; Massaia M; Boccadoro M;

Weekly infusion of bortezomib in combination with rituximab in relapsed/refractory indolent non-follicular and mantle cell lymphoma is safe and effective: Two-years analysis of phase II trial bril06 of Intergruppo Italiano Linfomi (IIL) in Blood

2010
AOU Città della Salute di Torino

Chiappella A; Pregno P; Zinzani PL; Evangelista A; Fabbri A; Facchetti F; Ferreri AJM; Franceschetti S; Freilone R; Gargantini L; Gioia D; Liberati AM; Nicolosi M; Orsucci L; Rigacci L; Russo E; Stefoni V; Tucci A; Vitolo U;

Prospective, multicenter phase I-II pilot trial to evaluate efficacy and safety of lenalidomide plus rituximab-CHOP21 (LR-CHOP21) for elderly patients with untreated diffuse large B-cell lymphoma (DLBCL): Interim analysis of the Intergruppo Italiano Linfomi (IIL) REAL07 study in Blood

2010
AOU Città della Salute di Torino

Vitolo U; Chiappella A; Carella AM; Baldi I; Ciccone G; Congiu A; Gaidano G; De Masi P; Ladetto M; Levis A; Liberati AM; Orsucci L; Pavone V; Perticone S; Tucci A; Zanni M; Rossi G;

Retrospective analysis of 206 mantle cell lymphoma patients at diagnosis: Mantle cell international prognostic index (MIPI) is a good predictor of death event in patients treated either with rituximab-chemotherapy or rituximab-high-dose-chemotherapy in Blood

2010
AOU Città della Salute di Torino

Chiappella A; Puccini B; Ferrero S; Arcaini L; Baldi I; Benevolo G; Boccomini C; Botto B; Ciochetto C; Cortelazzo S; Fabbri A; Frairia C; Gabutti C; Ladetto M; Mian M; Novero D; Orsucci L; Pregno P; Priolo G; Rigacci L; Rossi M; Rusconi C; Vitolo U;

High expression of mRNA and gene amplification of Met in myeloma plasma cells characterize a more aggressive disease in Blood

2010
AOU Città della Salute di Torino

Rocci A; Gambella M; Aschero S; Baldi I; Trusolino L; Cavallo F; Larocca A; Omedè P; Bertotti A; Montefusco V; Crippa C; Patriarca F; Marina Liberati A; Falcone A; Isaia G; Drandi D; Ladetto M; Comoglio PM; Ciccone G; Boccadoro M; Palumbo A;

A phase III study to compare Melphalan, Prednisone, Lenalidomide (MPR) versus melphalan 200 Mg/m2 and autologous transplantation (MEL200) in newly diagnosed multiple myeloma patients in Blood

2010
AOU Città della Salute di Torino

Palumbo A; Cavallo F; Hardan I; Ciccone G; Larocca A; Cavalli M; Peccatori J; Carella AM; Brioli A; Cafro AM; Patriarca F; Siniscalchi A; Pezzatti S; Crippa C; Montefusco I; Levi A; Ruggeri M; Caravita T; Yehuda DB; Di Raimondo F; Boccadoro M;

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens in Blood

2009
AOU Città della Salute di Torino

Kumar S; Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Lentzsch S; Munshi N; Niesvizky R; Miguel JS; Ludwig H; Bergsagel L; Blade J; Lonial S; Anderson KC; Tosi P; Sonneveld P; Sezer O; Vesole D; Cavo M; Einsele H; Richardson PG; Durie BGM; Rajkumar SV;

Bortezomib, melphalan, prednisone and thalidomide (VMPT) followed by maintenance with bortezomib and thalidomide for initial treatment of elderly multiple myeloma patients in Blood

2009
AO Ordine Mauriziano
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Rossi D; Ria R; Offidani M; Patriarca F; Nozzoli C; Levi A; Guglielmelli T; Benevolo G; Callea V; Olivero B; Morabito F; Grasso M; Marasca R; Rizzo M; Pia Falcone A; Gottardi D; Montefusco V; Musolino C; Zambello R; Cangialosi C; Pietrantuono G; Magarotto V; Petrucci MT; Musto P; Ciccone G; Di Raimondo F; Gaidano G; et alii...

Salvage treatment with lenalidomide and dexamethasone in patients with relapsed refractory mantle cell lymphoma in Blood

2009
AOU Città della Salute di Torino

Zaja F; De Luca S; Vitolo U; Orsucci L; Levis A; Salvi F; Gargantini L; Ravelli E; Tucci A; Bottelli C; Balzarotti M; Santoro A; Brusamolino E; Bonfichi M; Di Rocco A; Stelitano C; Baldini L; Aldo Pileri S; Volpetti S; Ciccone G; Ferranti A; Fanin R;

Long-term outcome of 309 young patients affected by diffuse large b-cell lymphoma (DLBCL) with a poor-prognosis at diagnosis: A pooled analysis from four consecutive trials of gimurell and italian lymphoma intergroup (IIL) in Blood

2009
AOU Città della Salute di Torino

Chiappella A; Giuseppina Cabras M; Marina Liberati A; Bottelli C; Ciccone G; Angelucci E; Baldini L; Botto B; Cascavilla N; Cortelazzo S; De Masi P; Falchi L; Fioritoni G; Frairia C; Freilone R; Levis A; Orsucci L; Parvis G; Maria Pogliani E; Rota-Scalabrini D; Salvi F; Specchia G; Tonso A; Tucci A; Vitolo U;

Mantle cell international prognostic index (MIPI) is a strong predictor of the outcome of mantle cell lymphoma (MCL) in the rituximab (R) era in Blood

2009
AOU Città della Salute di Torino

Chiappella A; Puccini B; Rossi M; Ferrero S; Arcaini L; Audisio E; Baldi I; Boccomini C; Botto B; Alberto F; Frairia C; Freilone R; Ladetto M; Novero D; Paulli M; Pregno P; Priolo G; Rigacci L; Vitolo U;

The combination of bortezomib and rituximab is effective and safe in relapsed/refractory indolent non follicular and mantle-cell non Hodgkin lymphoma: A phase II multicenter study by Intergruppo Italiano Linfomi in Blood

2009
AOU Città della Salute di Torino

Chiappella A; Pregno P; Zinzani PL; Facchetti F; Evangelista A; Fabbri A; Ferreri AJM; Franceschetti S; Freilone R; Gargantini L; Gioia D; Marina Liberati A; Orsucci L; Rigacci L; Russo E; Stefoni V; Tucci A; Vitolo U;

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: Updated results of a randomized controlled trial in Blood

2008
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Liberati AM; Caravita T; Falcone A; Callea V; Montanaro M; Ria R; Capaldi A; Zambello R; Benevolo G; Derudas D; Dore F; Cavallo F; Gay F; Falco P; Ciccone G; Musto P; Cavo M; Boccadoro M;

CD38 gene polymorphism and chronic lymphocytic leukemia: A role in transformation to Richter syndrome? in Blood

2008
AOU Città della Salute di Torino

Aydin S; Rossi D; Bergui L; D'Arena G; Ferrero E; Bonello L; Omedé P; Novero D; Morabito F; Carbone A; Gaidano G; Malavasi F; Deaglio S;

C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium in Blood

2007
AOU Città della Salute di Torino

Dentelli P; Rosso A; Balsamo A; Benedetto SC; Zeoli A; Pegoraro M; Camussi G; Pegoraro L; Brizzi MF;

Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. in Blood / Blood. 2005 Apr 15;105(8):3214-21. doi: 10.1182/blood-2004-07-2686. Epub 2004 Dec 30.

2005
AOU Città della Salute di Torino

Regis G; Bosticardo M; Conti L; De Angelis S; Boselli D; Tomaino B; Bernabei P; Giovarelli M; Novelli F;

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. in Blood / Blood. 2004 Nov 15;104(10):3052-7. doi: 10.1182/blood-2004-02-0408. Epub 2004 Jul 20.

2004
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Petrucci MT; Musto P; Rossini F; Nunzi M; Lauta VM; Bergonzi C; Barbui A; Caravita T; Capaldi A; Pregno P; Guglielmelli T; Grasso M; Callea V; Bertola A; Cavallo F; Falco P; Rus C; Massaia M; Mandelli F; Carella AM; Pogliani E; Liberati AM; Dammacco F; Ciccone G; Boccadoro M;

Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. in Blood / Blood. 1999 May 15;93(10):3531-9.

1999
AOU Città della Salute di Torino

Musso T; Calosso L; Zucca M; Millesimo M; Ravarino D; Giovarelli M; Malavasi F; Ponzi AN; Paus R; Bulfone-Paus S;

Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients in Blood

1999
AOU Città della Salute di Torino

Palumbo A; Triolo S; Argentino C; Bringhen S; Dominietto A; Rus C; Omedè P; Tarella C; Pileri A; Boccadoro M;

Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. in Blood / Blood. 1995 Jun 15;85(12):3679-87.

1995
AOU Città della Salute di Torino

Massaia M; Borrione P; Attisano C; Barral P; Beggiato E; Montacchini L; Bianchi A; Boccadoro M; Pileri A;

Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. in Blood / Blood. 1991 Oct 1;78(7):1770-80.

1991
AOU Città della Salute di Torino

Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A;